Global vascular guidelines on the management of chronic limb-threatening ischemia

Bypass surgery; Chronic limb-threatening ischemia; Critical limb ischemia; Diabetes; Endovascular intervention; Evidence-based medicine; Foot ulcer; Peripheral artery disease; Practice guideline; Article

Abstract :

[en] Chronic limb-threatening ischemia (CLTI)is associated with mortality, amputation, and impaired quality of life. These Global Vascular Guidelines (GVG)are focused on definition, evaluation, and management of CLTI with the goals of improving evidence-based care and highlighting critical research needs. The term CLTI is preferred over critical limb ischemia, as the latter implies threshold values of impaired perfusion rather than a continuum. CLTI is a clinical syndrome defined by the presence of peripheral artery disease (PAD)in combination with rest pain, gangrene, or a lower limb ulceration >2 weeks duration. Venous, traumatic, embolic, and nonatherosclerotic etiologies are excluded. All patients with suspected CLTI should be referred urgently to a vascular specialist. Accurately staging the severity of limb threat is fundamental, and the Society for Vascular Surgery Threatened Limb Classification system, based on grading of Wounds, Ischemia, and foot Infection (WIfI)is endorsed. Objective hemodynamic testing, including toe pressures as the preferred measure, is required to assess CLTI. Evidence-based revascularization (EBR)hinges on three independent axes: Patient risk, Limb severity, and ANatomic complexity (PLAN). Average-risk and high-risk patients are defined by estimated procedural and 2-year all-cause mortality. The GVG proposes a new Global Anatomic Staging System (GLASS), which involves defining a preferred target artery path (TAP)and then estimating limb-based patency (LBP), resulting in three stages of complexity for intervention. The optimal revascularization strategy is also influenced by the availability of autogenous vein for open bypass surgery. Recommendations for EBR are based on best available data, pending level 1 evidence from ongoing trials. Vein bypass may be preferred for average-risk patients with advanced limb threat and high complexity disease, while those with less complex anatomy, intermediate severity limb threat, or high patient risk may be favored for endovascular intervention. All patients with CLTI should be afforded best medical therapy including the use of antithrombotic, lipid-lowering, antihypertensive, and glycemic control agents, as well as counseling on smoking cessation, diet, exercise, and preventive foot care. Following EBR, long-term limb surveillance is advised. The effectiveness of nonrevascularization therapies (eg, spinal stimulation, pneumatic compression, prostanoids, and hyperbaric oxygen)has not been established. Regenerative medicine approaches (eg, cell, gene therapies)for CLTI should be restricted to rigorously conducted randomizsed clinical trials. The GVG promotes standardization of study designs and end points for clinical trials in CLTI. The importance of multidisciplinary teams and centers of excellence for amputation prevention is stressed as a key health system initiative. © 2019 Society for Vascular Surgery and European Society for Vascular Surgery

Disciplines :

Surgery

Author, co-author :

Conte, M. S.; Division of Vascular and Endovascular Surgery, University of California, San Francisco, Calif, United States

Bradbury, A. W.; Department of Vascular Surgery, University of Birmingham, Birmingham, United Kingdom

Kolh, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.

White, J. V.; Department of Surgery, Advocate Lutheran General Hospital, Niles, Ill, United States

Dick, F.; Department of Vascular Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland

Fitridge, R.; Department of Vascular and Endovascular Surgery, The University of Adelaide Medical School, Adelaide, Australia

Mills, J. L.; Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine, Houston, Tex, United States

Ricco, J.-B.; Department of Clinical Research, University Hospitalof Poitiers, Poitiers, France

Suresh, K. R.; Jain Institute of Vascular Sciences, Bangalore, India

Murad, M. H.; Mayo Clinic Evidence-Based Practice Center, Rochester, Minn, United States

More authors (43 more)

Title :

Global vascular guidelines on the management of chronic limb-threatening ischemia

Publication date :

2019

Journal title :

Journal of Vascular Surgery

ISSN :

0741-5214

eISSN :

1097-6809

Publisher :

Mosby Inc.

Volume :

Issue :

Pages :

3S-125S.e40

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 24 September 2019

Statistics

Number of views

1710 (9 by ULiège)

Number of downloads

1340 (2 by ULiège)

More statistics

Scopus citations^®

923

Scopus citations^®
without self-citations

820

OpenCitations

465

OpenAlex citations

1316

Bibliography

Fowkes, F.G., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J.O., McDermott, M.M., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
Goodney, P.P., Holman, K., Henke, P.K., Travis, L.L., Dimick, J.B., Stukel, T.A., et al. Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg 57 (2013), 1471–1479 1480.e1-3; discussion: 1479-80.
Goodney, P.P., Travis, L.L., Brooke, B.S., DeMartino, R.R., Goodman, D.C., Fisher, E.S., et al. Relationship between regional spending on vascular care and amputation rate. JAMA Surg 149 (2014), 34–42.
Abu Dabrh, A.M., Steffen, M.W., Asi, N., Undavalli, C., Wang, Z., Elamin, M.B., et al. Nonrevascularization-based treatments in patients with severe or critical limb ischemia. J Vasc Surg 62 (2015), 1330–1339.e13.
Abu Dabrh, A.M., Steffen, M.W., Undavalli, C., Asi, N., Wang, Z., Elamin, M.B., et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 62 (2015), 1642–1651.e3.
Abu Dabrh, A.M., Steffen, M.W., Asi, N., Undavalli, C., Wang, Z., Elamin, M.B., et al. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg 63 (2016), 244–253.e11.
Almasri, J., Adusumalli, J., Asi, N., Lakis, S., Alsawas, M., Prokop, L.J., et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg 68 (2018), 624–633.
Murad, M.H., Clinical practice guidelines: a primer on development and dissemination. Mayo Clin Proc 92 (2017), 423–433.
Guyatt, G.H., Alonso-Coello, P., Schunemann, H.J., Djulbegovic, B., Nothacker, M., Lange, S., et al. Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group. J Clin Epidemiol 80 (2016), 3–7.
Mills, J.L. Sr., Conte, M.S., Armstrong, D.G., Pomposelli, F.B., Schanzer, A., Sidawy, A.N., et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 59 (2014), 220–234.e1-2.
Jaff, M.R., White, C.J., Hiatt, W.R., Fowkes, G.R., Dormandy, J., Razavi, M., et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): the TASC Steering Committee. Catheter Cardiovasc Interv 86 (2015), 611–625.
Bollinger, A., Breddin, K., Hess, H., Heystraten, F.M., Kollath, J., Konttila, A., et al. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 38 (1981), 339–346.
Menard, M.T., Farber, A., Assmann, S.F., Choudhry, N.K., Conte, M.S., Creager, M.A., et al. Design and rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI)trial. J Am Heart Assoc, 5, 2016, e003219.
Popplewell, M.A., Davies, H., Jarrett, H., Bate, G., Grant, M., Patel, S., et al. Bypass versus angioplasty in severe ischaemia of the leg-2 (BASIL-2)trial: study protocol for a randomised controlled trial. Trials, 17, 2016, 11.
Hunt, B.D., Popplewell, M.A., Davies, H., Meecham, L., Jarrett, H., Bate, G., et al. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial. Trials, 18, 2017, 224.
de Graaff, J.C., Ubbink, D.T., Legemate, D.A., Tijssen, J.G., Jacobs, M.J., Evaluation of toe pressure and transcutaneous oxygen measurements in management of chronic critical leg ischemia: a diagnostic randomized clinical trial. J Vasc Surg 38 (2003), 528–534.
Brownrigg, J.R., Hinchliffe, R.J., Apelqvist, J., Boyko, E.J., Fitridge, R., Mills, J.L., et al. Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev 32:Suppl 1 (2016), 128–135.
Wang, Z., Hasan, R., Firwana, B., Elraiyah, T., Tsapas, A., Prokop, L., et al. A systematic review and meta-analysis of tests to predict wound healing in diabetic foot. J Vasc Surg 63 (2016), 29S–36S.e2.
Lijmer, J.G., Hunink, M.G., van den Dungen, J.J., Loonstra, J., Smit, A.J., ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 22 (1996), 391–398.
Dachun, X., Jue, L., Liling, Z., Yawei, X., Dayi, H., Pagoto, S.L., et al. Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review. Vasc Med 15 (2010), 361–369.
Aboyans, V., Ho, E., Denenberg, J.O., Ho, L.A., Natarajan, L., Criqui, M.H., The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 48 (2008), 1197–1203.
Salaun, P., Desormais, I., Lapebie, F.X., Riviere, A.B., Aboyans, V., Lacroix, P., et al. Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort. Angiology, 2018 3319718793566.
Shirasu, T., Hoshina, K., Akagi, D., Miyahara, T., Yamamoto, K., Watanabe, T., Pulse volume recordings to identify falsely elevated ankle brachial index. Asian Cardiovasc Thorac Ann 24 (2016), 517–522.
Hingorani, A.P., Ascher, E., Marks, N., Puggioni, A., Shiferson, A., Tran, V., et al. Limitations of and lessons learned from clinical experience of 1,020 duplex arteriography. Vascular 16 (2008), 147–153.
Larch, E., Minar, E., Ahmadi, R., Schnurer, G., Schneider, B., Stumpflen, A., et al. Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography. J Vasc Surg 25 (1997), 629–636.
Adriaensen, M.E., Kock, M.C., Stijnen, T., van Sambeek, M.R., van Urk, H., Pattynama, P.M., et al. Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations. Radiology 233 (2004), 385–391.
Hingorani, A., Ascher, E., Markevich, N., Kallakuri, S., Schutzer, R., Yorkovich, W., et al. A comparison of magnetic resonance angiography, contrast arteriography, and duplex arteriography for patients undergoing lower extremity revascularization. Ann Vasc Surg 18 (2004), 294–301.
Collins, R., Cranny, G., Burch, J., Aguiar-Ibanez, R., Craig, D., Wright, K., et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess, 11, 2007 iii-iv, xi-xiii, 1-184.
Met, R., Bipat, S., Legemate, D.A., Reekers, J.A., Koelemay, M.J., Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 301 (2009), 415–424.
Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities. Eur J Vasc Endovasc Surg 14 (1997), 91–95.
Armstrong, E.J., Wu, J., Singh, G.D., Dawson, D.L., Pevec, W.C., Amsterdam, E.A., et al. Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. J Vasc Surg 60 (2014), 1565–1571.
Faglia, E., Clerici, G., Scatena, A., Caminiti, M., Curci, V., Morabito, A., et al. Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study. Diabetes Res Clin Pract 103 (2014), 292–297.
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002), 71–86.
Antithrombotic Trialists’ Collaboration Baigent, C., Blackwell, L., Collins, R., Emberson, J., Godwin, J., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373 (2009), 1849–1860.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996), 1329–1339.
Hiatt, W.R., Fowkes, F.G., Heizer, G., Berger, J.S., Baumgartner, I., Held, P., et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med 376 (2017), 32–40.
Anand, S.S., Bosch, J., Eikelboom, J.W., Connolly, S.J., Diaz, R., Widimsky, P., et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 391 (2018), 219–229.
Anand, S., Yusuf, S., Xie, C., Pogue, J., Eikelboom, J., Budaj, A., et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357 (2007), 217–227.
Leng, G.C., Price, J.F., Jepson, R.G., Lipid-lowering for lower limb atherosclerosis. Cochrane Database Syst Rev, 2, 2000, CD000123.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002), 7–22.
Meade, T., Zuhrie, R., Cook, C., Cooper, J., Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ, 325, 2002, 1139.
Aung, P.P., Maxwell, H.G., Jepson, R.G., Price, J.F., Leng, G.C., Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev, 4, 2007, CD000123.
Mills, E.J., O'Regan, C., Eyawo, O., Wu, P., Mills, F., Berwanger, O., et al. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients. Eur Heart J 32 (2011), 1409–1415.
Rodriguez, F., Maron, D.J., Knowles, J.W., Virani, S.S., Lin, S., Heidenreich, P.A., Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease. JAMA Cardiol 2 (2017), 47–54.
ACCORD Study Group Cushman, W.C., Evans, G.W., Byington, R.P., Goff, D.C. Jr., Grimm, R.H. Jr., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362 (2010), 1575–1585.
Bavry, A.A., Anderson, R.D., Gong, Y., Denardo, S.J., Cooper-Dehoff, R.M., Handberg, E.M., et al. Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy. Hypertension 55 (2010), 48–53.
Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
Moise, N., Huang, C., Rodgers, A., Kohli-Lynch, C.N., Tzong, K.Y., Coxson, P.G., et al. Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: the Cardiovascular Disease Policy Model. Hypertension 68 (2016), 88–96.
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F.L., Powe, N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 (2004), 421–431.
Nathan, D.M., Cleary, P.A., Backlund, J.Y., Genuth, S.M., Lachin, J.M., Orchard, T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005), 2643–2653.
van Dieren, S., Kengne, A.P., Chalmers, J., Beulens, J.W., Davis, T.M., Fulcher, G., et al. Intensification of medication and glycaemic control among patients with type 2 diabetes—the ADVANCE trial. Diabetes Obes Metab 16 (2014), 426–432.
Fox, C.S., Golden, S.H., Anderson, C., Bray, G.A., Burke, L.E., de Boer, I.H., et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 38 (2015), 1777–1803.
American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018. Diabetes Care 41:Suppl 1 (2018), S55–S64.
Palmer, S.C., Mavridis, D., Nicolucci, A., Johnson, D.W., Tonelli, M., Craig, J.C., et al. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis. JAMA 316 (2016), 313–324.
Nawaz, S., Cleveland, T., Gaines, P.A., Chan, P., Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol 53 (1998), 342–344.
Goergen, S.K., Rumbold, G., Compton, G., Harris, C., Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology 254 (2010), 261–269.
Stacul, F., van der Molen, A.J., Reimer, P., Webb, J.A., Thomsen, H.S., Morcos, S.K., et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21 (2011), 2527–2541.
Dagenais, G.R., Yi, Q., Lonn, E., Sleight, P., Ostergren, J., Yusuf, S., Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE)trial. Eur J Cardiovasc Prev Rehabil 12 (2005), 75–81.
Athyros, V.G., Tziomalos, K., Katsiki, N., Gossios, T.D., Giouleme, O., Anagnostis, P., et al. The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study. Curr Vasc Pharmacol 11 (2013), 779–784.
Blomster, J.I., Woodward, M., Zoungas, S., Hillis, G.S., Harrap, S., Neal, B., et al. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation)trial. BMJ Open, 6, 2016, e009668.
Kondo, T., Osugi, S., Shimokata, K., Honjo, H., Morita, Y., Maeda, K., et al. Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers. Circ J 75 (2011), 2885–2892.
Newhall, K., Suckow, B., Spangler, E., Brooke, B.S., Schanzer, A., Tan, T.W., et al. Impact and duration of brief surgeon-delivered smoking cessation advice on attitudes regarding nicotine dependence and tobacco harms for patients with peripheral arterial disease. Ann Vasc Surg 38 (2017), 113–121.
Biancari, F., Salenius, J.P., Heikkinen, M., Luther, M., Ylonen, K., Lepantalo, M., Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg 31 (2007), 217–225 discussion: 226-7.
Schanzer, A., Mega, J., Meadows, J., Samson, R.H., Bandyk, D.F., Conte, M.S., Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 48 (2008), 1464–1471.
Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 51:Suppl (2010), 52S–68S.
Meltzer, A.J., Graham, A., Connolly, P.H., Meltzer, E.C., Karwowski, J.K., Bush, H.L., et al. The Comprehensive Risk Assessment for Bypass (CRAB)facilitates efficient perioperative risk assessment for patients with critical limb ischemia. J Vasc Surg 57 (2013), 1186–1195.
Simons, J.P., Goodney, P.P., Flahive, J., Hoel, A.W., Hallett, J.W., Kraiss, L.W., et al. A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass. J Vasc Surg 63 (2016), 990–997.
Cull, D.L., Manos, G., Hartley, M.C., Taylor, S.M., Langan, E.M., Eidt, J.F., et al. An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system. J Vasc Surg 60 (2014), 1535–1541.
Zhan, L.X., Branco, B.C., Armstrong, D.G., Mills, J.L. Sr., The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI)correlates with risk of major amputation and time to wound healing. J Vasc Surg 61 (2015), 939–944.
Causey, M.W., Ahmed, A., Wu, B., Gasper, W.J., Reyzelman, A., Vartanian, S.M., et al. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg 63 (2016), 1563–1573.e2.
Darling, J.D., McCallum, J.C., Soden, P.A., Meng, Y., Wyers, M.C., Hamdan, A.D., et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI)classification system following infrapopliteal endovascular interventions for critical limb ischemia. J Vasc Surg 64 (2016), 616–622.
Robinson, W.P., Loretz, L., Hanesian, C., Flahive, J., Bostrom, J., Lunig, N., et al. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI)score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center. J Vasc Surg 66 (2017), 488–498.e2.
Sheehan, P., Jones, P., Caselli, A., Giurini, J.M., Veves, A., Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26 (2003), 1879–1882.
Cardinal, M., Eisenbud, D.E., Phillips, T., Harding, K., Early healing rates and wound area measurements are reliable predictors of later complete wound closure. Wound Repair Regen 16 (2008), 19–22.
Lavery, L.A., Barnes, S.A., Keith, M.S., Seaman, J.W. Jr., Armstrong, D.G., Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. Diabetes Care 31 (2008), 26–29.
Snyder, R.J., Cardinal, M., Dauphinee, D.M., Stavosky, J., A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks. Ostomy Wound Manage 56 (2010), 44–50.
Seeger, J.M., Schmidt, J.H., Flynn, T.C., Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery. Ann Surg 205 (1987), 733–739.
Wengerter, K.R., Veith, F.J., Gupta, S.K., Ascer, E., Rivers, S.P., Influence of vein size (diameter)on infrapopliteal reversed vein graft patency. J Vasc Surg 11 (1990), 525–531.
Schanzer, A., Hevelone, N., Owens, C.D., Belkin, M., Bandyk, D.F., Clowes, A.W., et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 46 (2007), 1180–1190 discussion: 1190.
Harward, T.R., Ingegno, M.D., Carlton, L., Flynn, T.C., Seeger, J.M., Limb-threatening ischemia due to multilevel arterial occlusive disease. Simultaneous or staged inflow/outflow revascularization. Ann Surg 221 (1995), 498–503 discussion: 503-6.
Zukauskas, G., Ulevicius, H., Triponis, V., Sequential aortofemoropopliteal/distal bypass for treatment of critical lower-limb ischaemia. Cardiovasc Surg 3 (1995), 671–678.
Jongkind, V., Akkersdijk, G.J., Yeung, K.K., Wisselink, W., A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 52 (2010), 1376–1383.
Ye, W., Liu, C.W., Ricco, J.B., Mani, K., Zeng, R., Jiang, J., Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 53 (2011), 1728–1737.
Deloose, K., Bosiers, M., Callaert, J., Verbist, J., Vermassen, F., Scheinert, D., et al. Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results. J Cardiovasc Surg (Torino)58 (2017), 416–421.
Ricco, J.B., Probst, H., Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg 47 (2008), 45–53 discussion: 53-4.
Chiu, K.W., Davies, R.S., Nightingale, P.G., Bradbury, A.W., Adam, D.J., Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg 39 (2010), 460–471.
Indes, J.E., Pfaff, M.J., Farrokhyar, F., Brown, H., Hashim, P., Cheung, K., et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther 20 (2013), 443–455.
Kang, J.L., Patel, V.I., Conrad, M.F., Lamuraglia, G.M., Chung, T.K., Cambria, R.P., Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg 48 (2008), 872–877.
Ballotta, E., Gruppo, M., Mazzalai, F., Da Giau, G., Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery 147 (2010), 268–274.
Chang, R.W., Goodney, P.P., Baek, J.H., Nolan, B.W., Rzucidlo, E.M., Powell, R.J., Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 48 (2008), 362–367.
Baumann, F., Ruch, M., Willenberg, T., Dick, F., Do, D.D., Keo, H.H., et al. Endovascular treatment of common femoral artery obstructions. J Vasc Surg 53 (2011), 1000–1006.
Bonvini, R.F., Rastan, A., Sixt, S., Noory, E., Schwarz, T., Frank, U., et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol 58 (2011), 792–798.
Gouëffic, Y., Della Schiava, N., Thaveau, F., Rosset, E., Favre, J.P., Salomon du Mont, L., et al. Stenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv 10 (2017), 1344–1354.
Siracuse, J.J., Van Orden, K., Kalish, J.A., Eslami, M.H., Schermerhorn, M.L., Patel, V.I., et al. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg 65 (2017), 1039–1046.
Azuma, N., Uchida, H., Kokubo, T., Koya, A., Akasaka, N., Sasajima, T., Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?. Eur J Vasc Endovasc Surg 43 (2012), 322–328.
Sumpio, B.E., Forsythe, R.O., Ziegler, K.R., van Baal, J.G., Lepantalo, M.J., Hinchliffe, R.J., Clinical implications of the angiosome model in peripheral vascular disease. J Vasc Surg 58 (2013), 814–826.
Biancari, F., Juvonen, T., Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J Vasc Endovasc Surg 47 (2014), 517–522.
Chae, K.J., Shin, J.Y., Is angiosome-targeted angioplasty effective for limb salvage and wound healing in diabetic foot? A meta-analysis. PLoS One, 11, 2016, e0159523.
Jongsma, H., Bekken, J.A., Akkersdijk, G.P., Hoeks, S.E., Verhagen, H.J., Fioole, B., Angiosome-directed revascularization in patients with critical limb ischemia. J Vasc Surg 65 (2017), 1208–12019.e1.
Schillinger, M., Sabeti, S., Loewe, C., Dick, P., Amighi, J., Mlekusch, W., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006), 1879–1888.
Saxon, R.R., Dake, M.D., Volgelzang, R.L., Katzen, B.T., Becker, G.J., Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19 (2008), 823–832.
Dake, M.D., Ansel, G.M., Jaff, M.R., Ohki, T., Saxon, R.R., Smouse, H.B., et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4 (2011), 495–504.
Rosenfield, K., Jaff, M.R., White, C.J., Rocha-Singh, K., Mena-Hurtado, C., Metzger, D.C., et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373 (2015), 145–153.
Mills, J.L., Fujitani, R.M., Taylor, S.M., Contribution of routine intraoperative completion arteriography to early infrainguinal bypass patency. Am J Surg 164 (1992), 506–510 discussion: 510-1.
Bandyk, D.F., Mills, J.L., Gahtan, V., Esses, G.E., Intraoperative duplex scanning of arterial reconstructions: fate of repaired and unrepaired defects. J Vasc Surg 20 (1994), 426–432 discussion: 432-3.
Ubbink, D.T., Vermeulen, H., Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev, 2, 2013, CD004001.
Karanth, V.K., Karanth, T.K., Karanth, L., Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease. Cochrane Database Syst Rev, 12, 2016, CD011519.
Vietto, V., Franco, J.V., Saenz, V., Cytryn, D., Chas, J., Ciapponi, A., Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev, 1, 2018, CD006544.
Smith, F.B., Bradbury, A., Fowkes, G., Intravenous naftidrofuryl for critical limb ischaemia. Cochrane Database Syst Rev, 7, 2012, CD002070.
Kranke, P., Bennett, M.H., Martyn-St James, M., Schnabel, A., Debus, S.E., Weibel, S., Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev, 6, 2015, CD004123.
Game, F.L., Apelqvist, J., Attinger, C., Hartemann, A., Hinchliffe, R.J., Löndahl, M., et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev 32:Suppl 1 (2016), 154–168.
Santema, K.T., Stoekenbroek, R.M., Koelemay, M.J., Reekers, J.A., van Dortmont, L.M., Oomen, A., et al. Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care 41 (2018), 112–119.
Peeters Weem, S.M., Teraa, M., de Borst, G.J., Verhaar, M.C., Moll, F.L., Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials. Eur J Vasc Endovasc Surg 50 (2015), 775–783.
Elsherif, M., Tawfick, W., Canning, P., Hynes, N., Sultan, S., Quality of time spent without symptoms of disease or toxicity of treatment for transmetatarsal amputation versus digital amputation in diabetic patients with digital gangrene. Vascular 26 (2018), 142–150.
Aziz, H., Branco, B.C., Braun, J., Hughes, J.D., Goshima, K.R., Trinidad-Hernandez, M., et al. The influence of do-not-resuscitate status on the outcomes of patients undergoing emergency vascular operations. J Vasc Surg 61 (2015), 1538–1542.
Siracuse, J.J., Jones, D.W., Meltzer, E.C., Graham, A.R., Salzler, G.G., Connolly, P.H., et al. Impact of “do not resuscitate” status on the outcome of major vascular surgical procedures. Ann Vasc Surg 29 (2015), 1339–1345.
Reed, A.B., Delvecchio, C., Giglia, J.S., Major lower extremity amputation after multiple revascularizations: was it worth it?. Ann Vasc Surg 22 (2008), 335–340.
Rollins, D.L., Towne, J.B., Bernhard, V.M., Baum, P.L., Isolated profundaplasty for limb salvage. J Vasc Surg 2 (1985), 585–590.
Miksic, K., Novak, B., Profunda femoris revascularization in limb salvage. J Cardiovasc Surg (Torino)27 (1986), 544–552.
Ayoub, M.M., Solis, M.M., Rogers, J.J., Dalton, M.L., Thru-knee amputation: the operation of choice for non-ambulatory patients. Am Surg 59 (1993), 619–623.
Taylor, S.M., Kalbaugh, C.A., Cass, A.L., Buzzell, N.M., Daly, C.A., Cull, D.L., et al. “Successful outcome” after below-knee amputation: an objective definition and influence of clinical variables. Am Surg 74 (2008), 607–612 discussion: 612-3.
Webster, J.B., Hakimi, K.N., Czerniecki, J.M., Prosthetic fitting, use, and satisfaction following lower-limb amputation: a prospective study. J Rehabil Res Dev, 49, 2012, 1493.
Bradley, L., Kirker, S., Secondary prevention of arteriosclerosis in lower limb vascular amputees: a missed opportunity. Eur J Vasc Endovasc Surg 32 (2006), 491–493.
Glaser, J.D., Bensley, R.P., Hurks, R., Dahlberg, S., Hamdan, A.D., Wyers, M.C., et al. Fate of the contralateral limb after lower extremity amputation. J Vasc Surg 58 (2013), 1571–1577.e1.
Abbruzzese, T.A., Havens, J., Belkin, M., Donaldson, M.C., Whittemore, A.D., Liao, J.K., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004), 1178–1185.
Henke, P.K., Blackburn, S., Proctor, M.C., Stevens, J., Mukherjee, D., Rajagopalin, S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004), 357–365.
Brown, J., Lethaby, A., Maxwell, H., Wawrzyniak, A.J., Prins, M.H., Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev, 4, 2008, CD000535.
Bedenis, R., Lethaby, A., Maxwell, H., Acosta, S., Prins, M.H., Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev, 2, 2015, CD000535.
Suckow, B.D., Kraiss, L.W., Schanzer, A., Stone, D.H., Kalish, J., DeMartino, R.R., et al. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. J Vasc Surg 61 (2015), 126–133.
Hobbs, S.D., Bradbury, A.W., Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach. Eur J Vasc Endovasc Surg 26 (2003), 341–347.
Willigendael, E.M., Teijink, J.A., Bartelink, M.L., Peters, R.J., Buller, H.R., Prins, M.H., Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg 42 (2005), 67–74.
Belch, J.J., Dormandy, J., CASPAR Writing Committee. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR)trial. J Vasc Surg 52 (2010), 825–833 e1-e2.
Gassman, A.A., Degner, B.C., Al-Nouri, O., Philippi, L., Hershberger, R., Halandras, P., et al. Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency. Vascular 22 (2014), 105–111.
Cassar, K., Ford, I., Greaves, M., Bachoo, P., Brittenden, J., Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty. Br J Surg 92 (2005), 159–165.
Bhatt, D.L., Fox, K.A., Hacke, W., Berger, P.B., Black, H.R., Boden, W.E., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006), 1706–1717.
Tepe, G., Bantleon, R., Brechtel, K., Schmehl, J., Zeller, T., Claussen, C.D., et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol 22 (2012), 1998–2006.
Strobl, F.F., Brechtel, K., Schmehl, J., Zeller, T., Reiser, M.F., Claussen, C.D., et al. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease. J Endovasc Ther 20 (2013), 699–706.
Mills, J.L. Sr., Wixon, C.L., James, D.C., Devine, J., Westerband, A., Hughes, J.D., The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair. J Vasc Surg 33 (2001), 273–278 discussion: 278-80.
Landry, G.J., Moneta, G.L., Taylor, L.M., Edwards, J.M., Yeager, R.A., Porter, J.M., Long-term outcome of revised lower-extremity bypass grafts. J Vasc Surg 35 (2002), 56–63.
Nguyen, L.L., Conte, M.S., Menard, M.T., Gravereaux, E.C., Chew, D.K., Donaldson, M.C., et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg 40 (2004), 916–923.
Bui, T.D., Mills, J.L. Sr., Ihnat, D.M., Gruessner, A.C., Goshima, K.R., Hughes, J.D., The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance. J Vasc Surg 55 (2012), 346–352.
Humphries, M.D., Pevec, W.C., Laird, J.R., Yeo, K.K., Hedayati, N., Dawson, D.L., Early duplex scanning after infrainguinal endovascular therapy. J Vasc Surg 53 (2011), 353–358.
Elraiyah, T., Prutsky, G., Domecq, J.P., Tsapas, A., Nabhan, M., Frykberg, R.G., et al. A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers. J Vasc Surg 63:Suppl (2016), 59S–68S.e1-2.
Bell, P., The definition of critical ischaemia of a limb. Br J Surg, 69, 1982, S2.
Thompson, M.M., Sayers, R.D., Varty, K., Reid, A., London, N.J., Bell, P.R., Chronic critical leg ischaemia must be redefined. Eur J Vasc Surg 7 (1993), 420–426.
Hafner, J., Schaad, I., Schneider, E., Seifert, B., Burg, G., Cassina, P.C., Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol 43 (2000), 1001–1008.
Fontaine, R., Kim, M., Kieny, R., [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta 21 (1954), 499–533.
Meggitt, B., Surgical management of the diabetic foot. Br J Hosp Med 16 (1976), 227–232.
Wagner, F.W. Jr., The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2 (1981), 64–122.
Second European Consensus Document on chronic critical leg ischemia. Circulation 84:Suppl (1991), IV1–IV26.
Rutherford, R.B., Baker, J.D., Ernst, C., Johnston, K.W., Porter, J.M., Ahn, S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997), 517–538.
Armstrong, D.G., Lavery, L.A., Harkless, L.B., Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21 (1998), 855–859.
Macfarlane, R.M., Jeffcoate, W.J., Classification of diabetic foot ulcers: the S(AD)SAD system. Diabetic Foot 2 (1999), 123–126.
Dormandy, J.A., Rutherford, R.B., Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31:Pt 2 (2000), S1–S296.
Schaper, N.C., Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 20:Suppl 1 (2004), S90–S95.
Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45:Suppl S (2007), S5–S67.
Martinez-De Jesus, F.R., A checklist system to score healing progress of diabetic foot ulcers. Int J Low Extrem Wounds 9 (2010), 74–83.
Lipsky, B.A., Berendt, A.R., Cornia, P.B., Pile, J.C., Peters, E.J., Armstrong, D.G., et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54 (2012), e132–e173.
Adam, D.J., Beard, J.D., Cleveland, T., Bell, J., Bradbury, A.W., Forbes, J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005), 1925–1934.
Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 51:Suppl (2010), 18S–31S.
Shishehbor, M.H., Hammad, T.A., Zeller, T., Baumgartner, I., Scheinert, D., Rocha-Singh, K.J., An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines-recommended hemodynamic parameters to diagnose critical limb ischemia. J Vasc Surg 63 (2016), 1311–1317.
Conte, M.S., Geraghty, P.J., Bradbury, A.W., Hevelone, N.D., Lipsitz, S.R., Moneta, G.L., et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 50 (2009), 1462–1473.e1-3.
Beropoulis, E., Stavroulakis, K., Schwindt, A., Stachmann, A., Torsello, G., Bisdas, T., Validation of the Wound, Ischemia, foot Infection (WIfI)classification system in nondiabetic patients treated by endovascular means for critical limb ischemia. J Vasc Surg 64 (2016), 95–103.
Darling, J.D., McCallum, J.C., Soden, P.A., Guzman, R.J., Wyers, M.C., Hamdan, A.D., et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI)classification system after first-time lower extremity revascularizations. J Vasc Surg 65 (2017), 695–704.
Mathioudakis, N., Hicks, C.W., Canner, J.K., Sherman, R.L., Hines, K.F., Lum, Y.W., et al. The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI)classification system predicts wound healing but not major amputation in patients with diabetic foot ulcers treated in a multidisciplinary setting. J Vasc Surg 65 (2017), 1698–1705.e1.
Ward, R., Dunn, J., Clavijo, L., Shavelle, D., Rowe, V., Woo, K., Outcomes of critical limb ischemia in an urban, safety net hospital population with high WIfI amputation scores. Ann Vasc Surg 38 (2017), 84–89.
Tokuda, T., Hirano, K., Sakamoto, Y., Mori, S., Kobayashi, N., Araki, M., et al. Use of the Wound, Ischemia, foot Infection classification system in hemodialysis patients after endovascular treatment for critical limb ischemia. J Vasc Surg 67 (2018), 1762–1768.
White, J.V., Rutherford, R.B., Ryjewski, C., Chronic subcritical limb ischemia: a poorly recognized stage of critical limb ischemia. Semin Vasc Surg 20 (2007), 62–67.
Salaun, P., Desormais, I., Lapébie, F.X., Rivière, A.B., Aboyans, V., Lacroix, P., et al. Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort. Angiology, 2018 3319718793566.
Graziani, L., Silvestro, A., Bertone, V., Manara, E., Andreini, R., Sigala, A., et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 33 (2007), 453–460.
Ramanan, B., Ahmed, A., Wu, B., Causey, M.W., Gasper, W.J., Vartanian, S.M., et al. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program. J Vasc Surg 66 (2017), 1765–1774.
Kobayashi, N., Hirano, K., Yamawaki, M., Araki, M., Sakai, T., Sakamoto, Y., et al. Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia. Catheter Cardiovasc Interv 91 (2018), 505–514.
Leithead, C., Novak, Z., Spangler, E., Passman, M.A., Witcher, A., Patterson, M.A., et al. Importance of postprocedural Wound, Ischemia, and foot Infection (WIfI)restaging in predicting limb salvage. J Vasc Surg 67 (2018), 498–505.
Hirsch, A.T., Allison, M.A., Gomes, A.S., Corriere, M.A., Duval, S., Ershow, A.G., et al. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation 125 (2012), 1449–1472.
Marrett, E., DiBonaventura, M., Zhang, Q., Burden of peripheral arterial disease in Europe and the United States: a patient survey. Health Qual Life Outcomes, 11, 2013, 175.
Howard, D.P., Banerjee, A., Fairhead, J.F., Hands, L., Silver, L.E., Rothwell, P.M., Population-based study of incidence, risk factors, outcome, and prognosis of ischemic peripheral arterial events: implications for prevention. Circulation 132 (2015), 1805–1815.
Olinic, D.M., Spinu, M., Olinic, M., Homorodean, C., Tataru, D.A., Liew, A., et al. Epidemiology of peripheral artery disease in Europe: VAS Educational Paper. Int Angiol 37 (2018), 327–334.
Kojima, I., Ninomiya, T., Hata, J., Fukuhara, M., Hirakawa, Y., Mukai, N., et al. A low ankle brachial index is associated with an increased risk of cardiovascular disease: the Hisayama study. J Atheroscler Thromb 21 (2014), 966–973.
Sheng, C.S., Li, Y., Huang, Q.F., Kang, Y.Y., Li, F.K., Wang, J.G., Pulse waves in the lower extremities as a diagnostic tool of peripheral arterial disease and predictor of mortality in elderly Chinese. Hypertension 67 (2016), 527–534.
Desormais, I., Aboyans, V., Guerchet, M., Ndamba-Bandzouzi, B., Mbelesso, P., Dantoine, T., et al. Prevalence of peripheral artery disease in the elderly population in urban and rural areas of Central Africa: the EPIDEMCA study. Eur J Prev Cardiol 22 (2014), 1462–1472.
Newman, A.B., Siscovick, D.S., Manolio, T.A., Polak, J., Fried, L.P., Borhani, N.O., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS)Collaborative Research Group. Circulation 88 (1993), 837–845.
Criqui, M.H., McClelland, R.L., McDermott, M.M., Allison, M.A., Blumenthal, R.S., Aboyans, V., et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 56 (2010), 1506–1512.
Guerchet, M., Aboyans, V., Mbelesso, P., Mouanga, A.M., Salazar, J., Bandzouzi, B., et al. Epidemiology of peripheral artery disease in elder general population of two cities of Central Africa: Bangui and Brazzaville. Eur J Vasc Endovasc Surg 44 (2012), 164–169.
Forbang, N.I., Hughes-Austin, J.M., Allison, M.A., Criqui, M.H., Peripheral artery disease and non-coronary atherosclerosis in Hispanics: another paradox?. Prog Cardiovasc Dis 57 (2014), 237–243.
Aboyans, V., Criqui, M.H., McClelland, R.L., Allison, M.A., McDermott, M.M., Goff, D.C. Jr., et al. Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg 45 (2007), 319–327.
Criqui, M.H., Aboyans, V., Epidemiology of peripheral artery disease. Circ Res 116 (2015), 1509–1526.
Nehler, M.R., Duval, S., Diao, L., Annex, B.H., Hiatt, W.R., Rogers, K., et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg 60 (2014), 686–695.e2.
Criqui, M.H., Fronek, A., Barrett-Connor, E., Klauber, M.R., Gabriel, S., Goodman, D., The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985), 510–515.
Gallotta, G., Iazzetta, N., Milan, G., Ruocco, A., Napoli, C., Postiglione, A., Prevalence of peripheral arterial disease in an elderly rural population of southern Italy. Gerontology 43 (1997), 289–295.
Sigvant, B., Lundin, F., Nilsson, B., Bergqvist, D., Wahlberg, E., Differences in presentation of symptoms between women and men with intermittent claudication. BMC Cardiovasc Disord, 11, 2011, 39.
Moss, S.E., Klein, R., Klein, B.E., The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 22 (1999), 951–959.
Prompers, L., Schaper, N., Apelqvist, J., Edmonds, M., Jude, E., Mauricio, D., et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51 (2008), 747–755.
Ix, J.H., Biggs, M.L., Kizer, J.R., Mukamal, K.J., Djousse, L., Zieman, S.J., et al. Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study. Am J Epidemiol 174 (2011), 1036–1043.
Martinez-Aguilar, E., Orbe, J., Fernandez-Montero, A., Fernandez-Alonso, S., Rodriguez, J.A., Fernandez-Alonso, L., et al. Reduced high-density lipoprotein cholesterol: a valuable, independent prognostic marker in peripheral arterial disease. J Vasc Surg 66 (2017), 1527–15233.e1.
Ridker, P.M., Stampfer, M.J., Rifai, N., Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001), 2481–2485.
Peng, J., Luo, F., Ruan, G., Peng, R., Li, X., Hypertriglyceridemia and atherosclerosis. Lipids Health Dis, 16, 2017, 233.
Vliegenthart, R., Geleijnse, J.M., Hofman, A., Meijer, W.T., van Rooij, F.J., Grobbee, D.E., et al. Alcohol consumption and risk of peripheral arterial disease: the Rotterdam study. Am J Epidemiol 155 (2002), 332–338.
Kaufman, J.D., Adar, S.D., Barr, R.G., Budoff, M., Burke, G.L., Curl, C.L., et al. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study. Lancet 388 (2016), 696–704.
Khandanpour, N., Loke, Y.K., Meyer, F.J., Jennings, B., Armon, M.P., Homocysteine and peripheral arterial disease: systematic review and meta-analysis. Eur J Vasc Endovasc Surg 38 (2009), 316–322.
Prushik, S.G., Farber, A., Gona, P., Shrader, P., Pencina, M.J., D'Agostino, R.B. Sr., et al. Parental intermittent claudication as risk factor for claudication in adults. Am J Cardiol 109 (2012), 736–741.
Wassel, C.L., Lamina, C., Nambi, V., Coassin, S., Mukamal, K.J., Ganesh, S.K., et al. Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe)consortium. Atherosclerosis 222 (2012), 138–147.
Fowkes, F.G., Housley, E., Cawood, E.H., Macintyre, C.C., Ruckley, C.V., Prescott, R.J., Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991), 384–392.
Batty, G.D., Russ, T.C., Stamatakis, E., Kivimaki, M., Psychological distress and risk of peripheral vascular disease, abdominal aortic aneurysm, and heart failure: pooling of sixteen cohort studies. Atherosclerosis 236 (2014), 385–388.
Prompers, L., Huijberts, M., Apelqvist, J., Jude, E., Piaggesi, A., Bakker, K., et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50 (2007), 18–25.
Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G., et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26 (2007), 81–157.
Biancari, F., Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia. J Cardiovasc Surg (Torino)54 (2013), 663–669.
Ziegler-Graham, K., MacKenzie, E.J., Ephraim, P.L., Travison, T.G., Brookmeyer, R., Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 89 (2008), 422–429.
Peacock, J.M., Keo, H.H., Duval, S., Baumgartner, I., Oldenburg, N.C., Jaff, M.R., et al. The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis, 8, 2011, A141.
Moxey, P.W., Gogalniceanu, P., Hinchliffe, R.J., Loftus, I.M., Jones, K.J., Thompson, M.M., et al. Lower extremity amputations—a review of global variability in incidence. Diabet Med 28 (2011), 1144–1153.
Vamos, E.P., Bottle, A., Edmonds, M.E., Valabhji, J., Majeed, A., Millett, C., Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care 33 (2010), 2592–2597.
Lombardo, F.L., Maggini, M., De Bellis, A., Seghieri, G., Anichini, R., Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010. PLoS One, 9, 2014, e86405.
Hirsch, A.T., Haskal, Z.J., Hertzer, N.R., Bakal, C.W., Creager, M.A., Halperin, J.L., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease)endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 47 (2006), 1239–1312.
Sigvant, B., Lundin, F., Wahlberg, E., The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg 51 (2016), 395–403.
Nehler, M.R., Hiatt, W.R., Taylor, L.M. Jr., Is revascularization and limb salvage always the best treatment for critical limb ischemia?. J Vasc Surg 37 (2003), 704–708.
Nehler, M.R., McDermott, M.M., Treat-Jacobson, D., Chetter, I., Regensteiner, J.G., Functional outcomes and quality of life in peripheral arterial disease: current status. Vasc Med 8 (2003), 115–126.
National Institute for Health and Care Excellence. Peripheral arterial disease: diagnosis and management. Clinical guideline CG147. Available at: https://www.nice.org.uk/guidance/cg147/chapter/Recommendations. (Accessed 30 October 2018)
Reinecke, H., Unrath, M., Freisinger, E., Bunzemeier, H., Meyborg, M., Lüders, F., et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J 36 (2015), 932–938.
Behrendt, C.A., Sigvant, B., Szeberin, Z., Beiles, B., Eldrup, N., Thomson, I.A., et al. International variations in amputation practice: a VASCUNET report. Eur J Vasc Endovasc Surg 56 (2018), 391–399.
van Haelst, S.T., Koopman, C., den Ruijter, H.M., Moll, F.L., Visseren, F.L., Vaartjes, I., et al. Cardiovascular and all-cause mortality in patients with intermittent claudication and critical limb ischaemia. Br J Surg 105 (2018), 252–261.
Baubeta Fridh, E., Andersson, M., Thuresson, M., Sigvant, B., Kragsterman, B., Johansson, S., et al. Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study. Eur J Vasc Endovasc Surg 54 (2017), 480–486.
Ortmann, J., Nüesch, E., Traupe, T., Diehm, N., Baumgartner, I., Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemia. J Vasc Surg 55 (2012), 98–104.
Hobbs, S.D., Wilmink, A.B., Bradbury, A.W., Ethnicity and peripheral arterial disease. Eur J Vasc Endovasc Surg 25 (2003), 505–512.
Diehm, N., Shang, A., Silvestro, A., Do, D.D., Dick, F., Schmidli, J., et al. Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur J Vasc Endovasc Surg 31 (2006), 59–63.
Armstrong, E.J., Chen, D.C., Westin, G.G., Singh, S., McCoach, C.E., Bang, H., et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc, 3, 2014, e000697.
Soga, Y., Iida, O., Takahaera, M., Hirano, K., Suzuki, K., Kawasaki, D., et al. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv 7 (2014), 1444–1449.
Sampson, U.K., Fowkes, F.G., McDermott, M.M., Criqui, M.H., Aboyans, V., Norman, P.E., et al. Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart 9 (2014), 145–158.e21.
Cull, D.L., Langan, E.M., Gray, B.H., Johnson, B., Taylor, S.M., Open versus endovascular intervention for critical limb ischemia: a population-based study. J Am Coll Surg 210 (2010), 555–561.
Moxey, P.W., Hofman, D., Hinchliffe, R.J., Jones, K., Thompson, M.M., Holt, P.J., Epidemiological study of lower limb amputation in England between 2003 and 2008. Br J Surg 97 (2010), 1348–1353.
European Society of Radiology. Summary of the proceedings of the International Summit 2015: general and subspecialty radiology. Insights Imaging 7 (2015), 1–5.
Wolfe, J.H., Wyatt, M.G., Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 13 (1997), 578–582.
Conde, I.D., Erwin, P.A., Evaluation of the patient who presents with critical limb ischemia: diagnosis, prognosis, and medical management. Tech Vasc Interv Radiol 17 (2014), 140–146.
Morgan, M.B., Crayford, T., Murrin, B., Fraser, S.C., Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 33 (2001), 679–687.
Nguyen, L.L., Moneta, G.L., Conte, M.S., Bandyk, D.F., Clowes, A.W., Seely, B.L., Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg 44 (2006), 977–983 discussion: 983-4.
Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., Barshes, N.R., Corriere, M.A., Drachman, D.E., et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135 (2017), e726–e779.
Aboyans, V., Ricco, J.B., Bartelink, M.E., Björck, M., Brodmann, M., Cohnert, T., et al. Editor's choice—2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 55 (2018), 305–368.
Criqui, M.H., Fronek, A., Klauber, M.R., Barrett-Connor, E., Gabriel, S., The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 71 (1985), 516–522.
Feigelson, H.S., Criqui, M.H., Fronek, A., Langer, R.D., Molgaard, C.A., Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol 140 (1994), 526–534.
McGee, S.R., Boyko, E.J., Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med 158 (1998), 1357–1364.
Khan, N.A., Rahim, S.A., Anand, S.S., Simel, D.L., Panju, A., Does the clinical examination predict lower extremity peripheral arterial disease?. JAMA 295 (2006), 536–546.
Cournot, M., Boccalon, H., Cambou, J.P., Guilloux, J., Taraszkiewicz, D., Hanaire-Broutin, H., et al. Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects. J Vasc Surg 46 (2007), 1215–1221.
Armstrong, D.G., Lavery, L.A., Vela, S.A., Quebedeaux, T.L., Fleischli, J.G., Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 158 (1998), 289–292.
Kamei, N., Yamane, K., Nakanishi, S., Yamashita, Y., Tamura, T., Ohshita, K., et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications 19 (2005), 47–53.
Feng, Y., Schlosser, F.J., Sumpio, B.E., The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 50 (2009), 675–682.e1.
O'Brien, T., Karem, J., An initial evaluation of a proof-of-concept 128-Hz electronic tuning fork in the detection of peripheral neuropathy. J Am Podiatr Med Assoc 104 (2014), 134–140.
Lam, K., van Asten, S.A., Nguyen, T., La Fontaine, J., Lavery, L.A., Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review. Clin Infect Dis 63 (2016), 944–948.
Schaper, N.C., Van Netten, J.J., Apelqvist, J., Lipsky, B.A., Bakker, K., Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Res Clin Pract 124 (2017), 84–92.
Hirsch, A.T., Haskal, Z.J., Hertzer, N.R., Bakal, C.W., Creager, M.A., Halperin, J.L., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006), e463–e654.
Al-Qaisi, M., Nott, D.M., King, D.H., Kaddoura, S., Ankle brachial pressure index (ABPI): an update for practitioners. Vasc Health Risk Manag 5 (2009), 833–841.
Gornik, H.L., Rethinking the morbidity of peripheral arterial disease and the “normal” ankle-brachial index. J Am Coll Cardiol 53 (2009), 1063–1064.
Silvestro, A., Diehm, N., Savolainen, H., Do, D.D., Vogelea, J., Mahler, F., et al. Falsely high ankle-brachial index predicts major amputation in critical limb ischemia. Vasc Med 11 (2006), 69–74.
Aboyans, V., Criqui, M.H., Abraham, P., Allison, M.A., Creager, M.A., Diehm, C., et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 126 (2012), 2890–2909.
Tyrrell, M.R., Wolfe, J.H., Critical leg ischaemia: an appraisal of clinical definitions. Joint Vascular Research Group. Br J Surg 80 (1993), 177–180.
Castronuovo, J.J. Jr., Adera, H.M., Smiell, J.M., Price, R.M., Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg 26 (1997), 629–637.
Abbas, Z.G., Lutale, J.K., Game, F.L., Jeffcoate, W.J., Comparison of four systems of classification of diabetic foot ulcers in Tanzania. Diabet Med 25 (2008), 134–137.
Parisi, M.C., Zantut-Wittmann, D.E., Pavin, E.J., Machado, H., Nery, M., Jeffcoate, W.J., Comparison of three systems of classification in predicting the outcome of diabetic foot ulcers in a Brazilian population. Eur J Endocrinol 159 (2008), 417–422.
Santema, T.B., Lenselink, E.A., Balm, R., Ubbink, D.T., Comparing the Meggitt-Wagner and the University of Texas wound classification systems for diabetic foot ulcers: inter-observer analyses. Int Wound J 13 (2016), 1137–1141.
Swanberg, J., Nyman, R., Magnusson, A., Wanhainen, A., Selective intra-arterial dual-energy CT angiography (s-CTA)in lower extremity arterial occlusive disease. Eur J Vasc Endovasc Surg 48 (2014), 325–329.
Moneta, G.L., Yeager, R.A., Lee, R.W., Porter, J.M., Noninvasive localization of arterial occlusive disease: a comparison of segmental Doppler pressures and arterial duplex mapping. J Vasc Surg 17 (1993), 578–582.
Pinto, F., Lencioni, R., Napoli, V., Petrucci, R., Vignali, C., Armillotta, N., et al. Peripheral ischemic occlusive arterial disease: comparison of color Doppler sonography and angiography. J Ultrasound Med 15 (1996), 697–704 quiz: 705-6.
Hou, X.X., Chu, G.H., Yu, Y., Prospects of contrast-enhanced ultrasonography for the diagnosis of peripheral arterial disease: a meta-analysis. J Ultrasound Med 37 (2018), 1081–1090.
Ligush, J. Jr., Reavis, S.W., Preisser, J.S., Hansen, K.J., Duplex ultrasound scanning defines operative strategies for patients with limb-threatening ischemia. J Vasc Surg 28 (1998), 482–490 discussion: 490-1.
Proia, R.R., Walsh, D.B., Nelson, P.R., Connors, J.P., Powell, R.J., Zwolak, R.M., et al. Early results of infragenicular revascularization based solely on duplex arteriography. J Vasc Surg 33 (2001), 1165–1170.
Ota, H., Takase, K., Igarashi, K., Chiba, Y., Haga, K., Saito, H., et al. MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images. AJR Am J Roentgenol 182 (2004), 201–209.
Romano, M., Mainenti, P.P., Imbriaco, M., Amato, B., Markabaoui, K., Tamburrini, O., et al. Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement. Eur J Radiol 50 (2004), 303–308.
Edwards, A.J., Wells, I.P., Roobottom, C.A., Multidetector row CT angiography of the lower limb arteries: a prospective comparison of volume-rendered techniques and intra-arterial digital subtraction angiography. Clin Radiol 60 (2005), 85–95.
Heijenbrok-Kal, M.H., Kock, M.C., Hunink, M.G., Lower extremity arterial disease: multidetector CT angiography meta-analysis. Radiology 245 (2007), 433–439.
Thomsen, H.S., Morcos, S.K., ESUR guidelines on contrast media. Abdom Imaging 31 (2006), 131–140.
Smith-Bindman, R., Lipson, J., Marcus, R., Kim, K.P., Mahesh, M., Gould, R., et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169 (2009), 2078–2086.
Solomon, R., The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 68 (2005), 2256–2263.
ACR Committee on Drugs and Contrast Media. ACR manual on contrast media, version 10.3. Available at: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf Accessed October 30, 2018.
van der Molen, A.J., Reimer, P., Dekkers, I.A., Bongartz, G., Bellin, M.F., Bertolotto, M., et al. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 28 (2018), 2856–2869.
Spinazzi, A., Pozzi Mucelli, R., [Administration of iodinated contrast in patients with pre-existing renal failure: a review]. Radiol Med 107 (2004), 88–97.
Carpenter, J.P., Baum, R.A., Holland, G.A., Barker, C.F., Peripheral vascular surgery with magnetic resonance angiography as the sole preoperative imaging modality. J Vasc Surg 20 (1994), 861–871.
Mell, M., Tefera, G., Thornton, F., Siepman, D., Turnipseed, W., Clinical utility of time-resolved imaging of contrast kinetics (TRICKS)magnetic resonance angiography for infrageniculate arterial occlusive disease. J Vasc Surg 45 (2007), 543–548 discussion: 548.
Kreitner, K.F., Kunz, R.P., Herber, S., Martenstein, S., Dorweiler, B., Dueber, C., MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA. J Magn Reson Imaging 27 (2008), 78–85.
Menke, J., Larsen, J., Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med 153 (2010), 325–334.
Altaha, M.A., Jaskolka, J.D., Tan, K., Rick, M., Schmitt, P., Menezes, R.J., et al. Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS)and TSE-based subtraction techniques. Eur Radiol 27 (2017), 1218–1226.
Kribben, A., Witzke, O., Hillen, U., Barkhausen, J., Daul, A.E., Erbel, R., Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J Am Coll Cardiol 53 (2009), 1621–1628.
Turowski, B., Schramm, P., An appeal to standardize CT- and MR-perfusion. Clin Neuroradiol 25 (2015), 205–210.
Grözinger, G., Pohmann, R., Schick, F., Grosse, U., Syha, R., Brechtel, K., et al. Perfusion measurements of the calf in patients with peripheral arterial occlusive disease before and after percutaneous transluminal angioplasty using MR arterial spin labeling. J Magn Reson Imaging 40 (2014), 980–987.
Hingorani, A., Ascher, E., Markevich, N., Kallakuri, S., Hou, A., Schutzer, R., et al. Magnetic resonance angiography versus duplex arteriography in patients undergoing lower extremity revascularization: which is the best replacement for contrast arteriography?. J Vasc Surg 39 (2004), 717–722.
Lapeyre, M., Kobeiter, H., Desgranges, P., Rahmouni, A., Becquemin, J.P., Luciani, A., Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 185 (2005), 1641–1650.
Hessel, S.J., Adams, D.F., Abrams, H.L., Complications of angiography. Radiology 138 (1981), 273–281.
Aspelin, P., Aubry, P., Fransson, S.G., Strasser, R., Willenbrock, R., Berg, K.J., Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003), 491–499.
Baker, C.S., Wragg, A., Kumar, S., De Palma, R., Baker, L.R., Knight, C.J., A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41 (2003), 2114–2118.
Waugh, J.R., Sacharias, N., Arteriographic complications in the DSA era. Radiology 182 (1992), 243–246.
Palena, L.M., Diaz-Sandoval, L.J., Candeo, A., Brigato, C., Sultato, E., Manzi, M., Automated carbon dioxide angiography for the evaluation and endovascular treatment of diabetic patients with critical limb ischemia. J Endovasc Ther 23 (2016), 40–48.
Jens, S., Marquering, H.A., Koelemay, M.J., Reekers, J.A., Perfusion angiography of the foot in patients with critical limb ischemia: description of the technique. Cardiovasc Intervent Radiol 38 (2015), 201–205.
Vierthaler, L., Callas, P.W., Goodney, P.P., Schanzer, A., Patel, V.I., Cronenwett, J., et al. Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia. J Vasc Surg 62 (2015), 655–664.e8.
Marston, W.A., Davies, S.W., Armstrong, B., Farber, M.A., Mendes, R.C., Fulton, J.J., et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 44 (2006), 108–114.
Critical Leg Ischaemia Prevention Study (CLIPS)Group Catalano, M., Born, G., Peto, R., Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med 261 (2007), 276–284.
Bonaca, M.P., Bhatt, D.L., Storey, R.F., Steg, P.G., Cohen, M., Kuder, J., et al. Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease. J Am Coll Cardiol 67 (2016), 2719–2728.
Bonaca, M.P., Creager, M.A., Olin, J., Scirica, B.M., Gilchrist, I.C., Murphy, S.A., et al. Peripheral revascularization in patients with peripheral artery disease with vorapaxar: insights from the TRA 2°P-TIMI 50 Trial. JACC Cardiovasc Interv 9 (2016), 2157–2164.
Sharma, A., Helft, G., Garg, A., Agrawal, S., Chatterjee, S., Lavie, C.J., et al. Safety and efficacy of vorapaxar in secondary prevention of atherosclerotic disease: a meta-analysis of randomized control trials. Int J Cardiol 227 (2017), 617–624.
Morrow, D.A., Braunwald, E., Bonaca, M.P., Ameriso, S.F., Dalby, A.J., Fish, M.P., et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 366 (2012), 1404–1413.
Bonaca, M.P., Scirica, B.M., Braunwald, E., Wiviott, S.D., Goto, S., Nilsen, D.W., et al. New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2°P-TIMI 50 Trial. J Am Coll Cardiol 64 (2014), 2318–2326.
Katsanos, K., Spiliopoulos, S., Saha, P., Diamantopoulos, A., Karunanithy, N., Krokidis, M., et al. Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis. PLoS One, 10, 2015, e0135692.
Bonaca, M.P., Gutierrez, J.A., Creager, M.A., Scirica, B.M., Olin, J., Murphy, S.A., et al. Acute limb ischemia and outcomes with vorapaxar in patients with peripheral artery disease: results from the Trial to Assess The effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients with Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Circulation 133 (2016), 997–1005.
Whayne, T.F., A review of the role of anticoagulation in the treatment of peripheral arterial disease. Int J Angiol 21 (2012), 187–194.
Fanari, Z., Malodiya, A., Weiss, S.A., Hammami, S., Kolm, P., Weintraub, W.S., Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: meta-analysis of randomized controlled trials. Cardiovasc Revasc Med 18 (2017), 10–15.
Anand, S.S., Caron, F., Eikelboom, J.W., Bosch, J., Dyal, L., Aboyans, V., et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol 71 (2018), 2306–2315.
Capell, W.H., Bonaca, M.P., Nehler, M.R., Chen, E., Kittelson, J.M., Anand, S.S., et al. Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD). Am Heart J 199 (2018), 83–91.
Ross, R., Atherosclerosis—an inflammatory disease. N Engl J Med 340 (1999), 115–126.
Libby, P., Ridker, P.M., Hansson, G.K., Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54 (2009), 2129–2138.
Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M.B., Thompson, S.G., Collins, R., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375 (2010), 132–140.
McDermott, M.M., Guralnik, J.M., Corsi, A., Albay, M., Macchi, C., Bandinelli, S., et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 150 (2005), 276–281.
Ridker, P.M., Danielson, E., Fonseca, F.A., Genest, J., Gotto, A.M., Kastelein, J.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008), 2195–2207.
Ridker, P.M., MacFadyen, J., Libby, P., Glynn, R.J., Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Am J Cardiol 106 (2010), 204–209.
Rogers, S.L., Magliano, D.J., Levison, D.B., Webb, K., Clarke, P.J., Grobler, M.P., et al. A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin. Clin Ther 29 (2007), 242–252.
Foley, T.R., Singh, G.D., Kokkinidis, D.G., Choy, H.K., Pham, T., Amsterdam, E.A., et al. High-intensity statin therapy is associated with improved survival in patients with peripheral artery disease. J Am Heart Assoc, 6, 2017, e005699.
Arya, S., Khakharia, A., Binney, Z.O., DeMartino, R.R., Brewster, L.P., Goodney, P.P., et al. Association of statin dose with amputation and survival in patients with peripheral artery disease. Circulation 137 (2018), 1435–1446.
Stone, N.J., Robinson, J.G., Lichtenstein, A.H., Bairey Merz, C.N., Blum, C.B., Eckel, R.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:Pt B (2014), 2889–2934.
Grundy, S.M., Stone, N.J., Bailey, A.L., Beam, C., Birtcher, K.K., Blumenthal, R.S., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2018 Nov 8 [Epub ahead of print].
Bonaca, M.P., Nault, P., Giugliano, R.P., Keech, A.C., Pineda, A.L., Kanevsky, E., et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk). Circulation 137 (2018), 338–350.
Williamson, J.D., Supiano, M.A., Applegate, W.B., Berlowitz, D.R., Campbell, R.C., Chertow, G.M., et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 315 (2016), 2673–2682.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002), 2981–2997.
Piller, L.B., Simpson, L.M., Baraniuk, S., Habib, G.B., Rahman, M., Basile, J.N., et al. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. J Gen Intern Med 29 (2014), 1475–1483.
Kray, J.E., Dombrovskiy, V.Y., Vogel, T.R., Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization. Vasc Health Risk Manag 13 (2017), 269–274.
Høgh, A., Lindholt, J.S., Nielsen, H., Jensen, L.P., Johnsen, S.P., Use of angiotensin-converting enzyme inhibitors and cardiovascular outcomes following primary vascular surgery: a nationwide propensity score matched follow-up study. Vasc Endovascular Surg 46 (2012), 515–523.
Hogh, A., Lindholt, J.S., Nielsen, H., Jensen, L.P., Johnsen, S.P., Beta-blocker use and clinical outcomes after primary vascular surgery: a nationwide propensity score-matched study. Eur J Vasc Endovasc Surg 46 (2013), 93–102.
Attaei, M.W., Khatib, R., McKee, M., Lear, S., Dagenais, G., Igumbor, E.U., et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health 2 (2017), e411–e419.
Paravastu, S.C., Mendonca, D.A., Da Silva, A., Beta blockers for peripheral arterial disease. Cochrane Database Syst Rev, 9, 2013, CD005508.
Thomas Manapurathe, D., Krishna, S.M., Dewdney, B., Moxon, J.V., Biros, E., Golledge, J., Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: a meta-analysis of randomised controlled trials. PLoS One, 12, 2017, e0178713.
Britton, K.A., Mukamal, K.J., Ix, J.H., Siscovick, D.S., Newman, A.B., de Boer, I.H., et al. Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study. Vasc Med 17 (2012), 85–93.
Joosten, M.M., Pai, J.K., Bertoia, M.L., Rimm, E.B., Spiegelman, D., Mittleman, M.A., et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA 308 (2012), 1660–1667.
Neal, B., Perkovic, V., Mahaffey, K.W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., Matthews, D.R., CANVAS Program Collaborative Group. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med 377:7 (2017 Aug 17), 644–657, 10.1056/NEJMoa1611925. Epub 2017 Jun 12 PMID:28605608.
Li, D., Yang, J.Y., Wang, T., Shen, S., Tang, H., Risks of diabetic foot syndrome and amputation associated with sodium glucose co-transporter 2 inhibitors: A Meta-analysis of Randomized Controlled Trials. Diabetes Metab 44:5 (2018 Nov), 410–414, 10.1016/j.diabet.2018.02.001 Epub 2018 Feb 13 PMID:29506779.
https://www.fda.gov/Drugs/DrugSafety/ucm557507.htm.
Potier, L., Roussel, R., Velho, G., Saulnier, P.J., Bumbu, A., Matar, O., Schneider, F., Ragot, S., Marre, M., Mohammedi, K., Hadjadj, S., Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use. Diabetologia, 2019 Feb 26, 10.1007/s00125-019-4835-z [Epub ahead of print]PMID:30809716.
Home, P., Cardiovascular outcome trials of glucose-lowering medications: an update. Diabetologia 62 (2019), 357–369.
Baggish, A.L., Weiner, R.B., Kanayama, G., Hudson, J.I., Lu, M.T., Hoffmann, U., et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation 135 (2017), 1991–2002.
Sandfort, V., Bluemke, D.A., Vargas, J., Brinker, J.A., Gerstenblith, G., Kickler, T., et al. Coronary plaque progression and regression in asymptomatic African American chronic cocaine users with obstructive coronary stenoses: a preliminary study. J Addict Med 11 (2017), 126–137.
Orr, K.K., Asal, N.J., Efficacy of electronic cigarettes for smoking cessation. Ann Pharmacother 48 (2014), 1502–1506.
Dehghan, M., Mente, A., Zhang, X., Swaminathan, S., Li, W., Mohan, V., et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet 390 (2017), 2050–2062.
Kok, F.J., Kromhout, D., Atherosclerosis—epidemiological studies on the health effects of a Mediterranean diet. Eur J Nutr 43:Suppl 1 (2004), I/2–I/5.
Bhupathiraju, S.N., Tucker, K.L., Coronary heart disease prevention: nutrients, foods, and dietary patterns. Clin Chim Acta 412 (2011), 1493–1514.
Nosova, E.V., Conte, M.S., Grenon, S.M., Advancing beyond the “heart-healthy diet” for peripheral arterial disease. J Vasc Surg 61 (2015), 265–274.
Vincent-Baudry, S., Defoort, C., Gerber, M., Bernard, M.C., Verger, P., Helal, O., et al. The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin Nutr 82 (2005), 964–971.
Miller, V., Yusuf, S., Chow, C.K., Dehghan, M., Corsi, D.J., Lock, K., et al. Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE)study. Lancet Glob Health 4 (2016), e695–e703.
Lane, R., Ellis, B., Watson, L., Leng, G.C., Exercise for intermittent claudication. Cochrane Database Syst Rev, 7, 2014, CD000990.
Anderson, L., Thompson, D.R., Oldridge, N., Zwisler, A.D., Rees, K., Martin, N., et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev, 1, 2016, CD001800.
Shaffer, E.E., Pham, A., Woldman, R.L., Spiegelman, A., Strassels, S.A., Wan, G.J., et al. Estimating the effect of intravenous acetaminophen for postoperative pain management on length of stay and inpatient hospital costs. Adv Ther 33 (2016), 2211–2228.
Helander, E.M., Menard, B.L., Harmon, C.M., Homra, B.K., Allain, A.V., Bordelon, G.J., et al. Multimodal analgesia, current concepts, and acute pain considerations. Curr Pain Headache Rep, 21, 2017, 3.
Sianos, G., Morel, M.A., Kappetein, A.P., Morice, M.C., Colombo, A., Dawkins, K., et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1 (2005), 219–227.
Kolh, P., Windecker, S., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC)and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 46 (2014), 517–592.
Rocha-Singh, K.J., Zeller, T., Jaff, M.R., Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 83 (2014), E212–E220.
Patel, M.R., Conte, M.S., Cutlip, D.E., Dib, N., Geraghty, P., Gray, W., et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 65 (2015), 931–941.
Davies, M.G., Feeley, T.M., O'Malley, M.K., Colgan, M.P., Moore, D.J., Shanik, G.D., Infrainguinal polytetrafluoroethylene grafts: saved limbs or wasted effort? A report on ten years' experience. Ann Vasc Surg 5 (1991), 519–524.
Donaldson, M.C., Mannick, J.A., Whittemore, A.D., Femoral-distal bypass with in situ greater saphenous vein. Long-term results using the Mills valvulotome. Ann Surg 213 (1991), 457–464 discussion: 464-5.
O'Riordain, D.S., Buckley, D.J., O'Donnell, J.A., Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. Am J Surg 164 (1992), 129–131.
Smith, F.C., Thomson, I.A., Hickey, N.C., Paterson, I.S., Tsang, G.M., Simms, M.H., et al. Adjuvant prostanoid treatment during femorodistal reconstruction. Ann Vasc Surg 7 (1993), 88–94.
Sayers, R.D., Thompson, M.M., Dunlop, P., London, N.J., Bell, P.R., The fate of infrainguinal PTFE grafts and an analysis of factors affecting outcome. Eur J Vasc Surg 8 (1994), 607–610.
Hearn, A.T., Smith, J.M., Welling, R.E., Lohr, J.M., Thibodeaux, L.C., Analysis of autogenous vein femoral-infrapopliteal bypass for limb salvage in the elderly. Cardiovasc Surg 4 (1996), 105–109.
Panayiotopoulos, Y.P., Reidy, J.F., Taylor, P.R., The concept of knee salvage: why does a failed femorocrural/pedal arterial bypass not affect the amputation level?. Eur J Vasc Endovasc Surg 13 (1997), 477–485.
Wijesinghe, L.D., Beardsmore, D.M., Scott, D.J., Polytetrafluoroethylene (PTFE)femorodistal grafts with a distal vein cuff for critical ischaemia. Eur J Vasc Endovasc Surg 15 (1998), 449–453.
Hamsho, A., Nott, D., Harris, P.L., Prospective randomised trial of distal arteriovenous fistula as an adjunct to femoro-infrapopliteal PTFE bypass. Eur J Vasc Endovasc Surg 17 (1999), 197–201.
Johnson, W.C., Lee, K.K., A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32 (2000), 268–277.
Ruckert, R.I., Settmacher, U., Kruger, U., Scholz, H., Femorodistal PTFE bypass grafting for severe limb ischaemia: results of a prospective clinical study using a new distal anastomotic technique. Eur J Vasc Endovasc Surg 20 (2000), 51–56.
Soder, H.K., Manninen, H.I., Jaakkola, P., Matsi, P.J., Rasanen, H.T., Kaukanen, E., et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 11 (2000), 1021–1031.
Dorros, G., Jaff, M.R., Dorros, A.M., Mathiak, L.M., He, T., Tibioperoneal (outflow lesion)angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 104 (2001), 2057–2062.
Schneider, P.A., Caps, M.T., Ogawa, D.Y., Hayman, E.S., Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg 33 (2001), 955–962.
Klinkert, P., Van Dijk, P.J.E., Breslau, P.J., Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage. Ann Vasc Surg 17 (2003), 486–491.
Hynes, N., Akhtar, Y., Manning, B., Aremu, M., Oiakhinan, K., Courtney, D., et al. Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease. J Endovasc Ther 11 (2004), 460–471.
Pedersen, G., Laxdal, E., Hagala, M., Amundsen, S.R., Dregelid, E., Aune, S., The impact of patient characteristics on long-term results of above-knee prosthetic femoropopliteal bypass for critical ischemia. Int Angiol 24 (2005), 349–354.
Surowiec, S.M., Davies, M.G., Eberly, S.W., Rhodes, J.M., Illig, K.A., Shortell, C.K., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 41 (2005), 269–278.
Ascher, E., Marks, N.A., Hingorani, A.P., Schutzer, R.W., Mutyala, M., Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases. J Vasc Surg 44 (2006), 1230–1237.
Bosiers, M., Hart, J.P., Deloose, K., Verbist, J., Peeters, P., Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 14 (2006), 63–69.
Peeters, P., Verbist, J., Deloose, K., Bosiers, M., Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses. J Cardiovasc Surg (Torino)47 (2006), 407–413.
DeRubertis, B.G., Pierce, M., Chaer, R.A., Rhee, S.J., Benjeloun, R., Ryer, E.J., et al. Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 46 (2007), 709–716.
Jensen, L.P., Lepantalo, M., Fossdal, J.E., Roder, O.C., Jensen, B.S., Madsen, M.S., et al. Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study. Eur J Vasc Endovasc Surg 34 (2007), 44–49.
Bosiers, M., Kallakuri, S., Deloose, K., Verbist, J., Peeters, P., Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent. EuroIntervention 3 (2008), 470–474.
Dosluoglu, H.H., Cherr, G.S., Lall, P., Harris, L.M., Dryjski, M.L., Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease. J Vasc Surg 48 (2008), 1166–1174.
Giles, K.A., Pomposelli, F.B., Hamdan, A.D., Blattman, S.B., Panossian, H., Schermerhorn, M.L., Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 48 (2008), 128–136.
Peeters, P., Verbist, J., Deloose, K., Bosiers, M., Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass?. Ital J Vasc Endovasc Surg 15 (2008), 143–148.
Peregrin, J.H., Smirova, S., Koznar, B., Novotny, J., Kovac, J., Lastovickova, J., et al. Self-expandable stent placement in infrapopliteal arteries after unsuccessful angioplasty failure: one-year follow-up. Cardiovasc Intervent Radiol 31 (2008), 860–864.
Ah Chong, A.K., Tan, C.B., Wong, M.W., Cheng, F.S., Bypass surgery or percutaneous transluminal angioplasty to treat critical lower limb ischaemia due to infrainguinal arterial occlusive disease?. Hong Kong Med J 15 (2009), 249–254.
Deloose, K., Bosiers, M., Peeters, P., One year outcome after primary stenting of infrapopliteal lesions with the Chromis Deep stent in the management of critical limb ischaemia. EuroIntervention 5 (2009), 318–324.
Randon, C., Vermassen, F., Jacobs, B., Deryck, F., Long-term results of femorodistal reconstructions with cryopreserved saphenous vein allografts. Interact Cardiovasc Thorac Surg, 8(Suppl 1), 2009, S27.
Setacci, C., Chisci, E., de Donato, G., Setacci, F., Iacoponi, F., Galzerano, G., Subintimal angioplasty with the aid of a re-entry device for TASC C and D lesions of the SFA. Eur J Vasc Endovasc Surg 38 (2009), 76–87.
Siablis, D., Karnabatidis, D., Katsanos, K., Diamantopoulos, A., Spiliopoulos, S., Kagadis, G.C., et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 20 (2009), 1141–1150.
Rastan, A., Schwarzwalder, U., Noory, E., Taieb, F.H., Beschorner, U., Sixt, S., et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther 17 (2010), 480–487.
Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 51:Suppl (2010), 5S–17S.
Feiring, A.J., Krahn, M., Nelson, L., Wesolowski, A., Eastwood, D., Szabo, A., Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts)trial. J Am Coll Cardiol 55 (2010), 1580–1589.
Fransson, T., Thorne, J., In situ saphenous vein bypass grafting—still first line treatment? A prospective study comparing surgical results between diabetic and non-diabetic populations. Vasa 39 (2010), 59–65.
Schmidt, A., Ulrich, M., Winkler, B., Klaeffling, C., Bausback, Y., Bräunlich, S., et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 76 (2010), 1047–1054.
Lindholt, J.S., Gottschalksen, B., Johannesen, N., Dueholm, D., Ravn, H., Christensen, E.D., et al. The Scandinavian Propaten Trial—1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses—a randomised clinical controlled multi-centre trial. Eur J Vasc Endovasc Surg 41 (2011), 668–673.
Rastan, A., Tepe, G., Krankenberg, H., Zahorsky, R., Beschorner, U., Noory, E., et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J 32 (2011), 2274–2281.
Bosiers, M., Scheinert, D., Peeters, P., Torsello, G., Zeller, T., Deloose, K., et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 55 (2012), 390–398.
Shammas, N.W., Lam, R., Mustapha, J., Ellichman, J., Aggarwala, G., Rivera, E., et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther 19 (2012), 480–488.
Baumann, F., Bloesch, S., Engelberger, R.P., Makaloski, V., Fink, H., Do, D.D., et al. Clinically-driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia. J Endovasc Ther 20 (2013), 707–713.
Baumann, F., Bloesch, S., Engelberger, R.P., Makaloski, V., Fink, H.P., Do, D.D., et al. Clinically driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia. Vasa, 42(Suppl 84), 2013, 57.
Liistro, F., Porto, I., Angioli, P., Grotti, S., Ricci, L., Ducci, K., et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 128 (2013), 615–621.
Lo, R.C., Darling, J., Bensley, R.P., Giles, K.A., Dahlberg, S.E., Hamdan, A.D., et al. Outcomes following infrapopliteal angioplasty for critical limb ischemia. J Vasc Surg 57 (2013), 1455–1464.
McKinsey, J.F., Zeller, T., Rocha-Singh, K.J., Jaff, M.R., Garcia, L.A., DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 7 (2014), 923–933.
Singh, G.D., Armstrong, E.J., Yeo, K.K., Singh, S., Westin, G.G., Pevec, W.C., et al. Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia. J Vasc Surg 59 (2014), 1300–1307.
Zeller, T., Baumgartner, I., Scheinert, D., Brodmann, M., Bosiers, M., Micari, A., et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 64 (2014), 1568–1576.
Bosiers, M., Keirse, K., Hendriks, J., Peeters, P., Maene, L., Bouchez, D., et al. The PES-BTK-70 study: final results of the assessment of the first self-expanding nitinol paclitaxel eluting stent in below-the-knee lesions. EuroIntervention, 2015 20150519(20150522).
Lee, J.H., Oh, J., Ko, Y.G., Rha, S.W., Kim, K.C., Park, S.H., et al. Impact of nitinol self-expanding stent on the patency of subintimal angioplasty for below-the-knee occlusions with critical limb ischemia (NEXSIA-BTK): multicenter, prospective registry. J Am Coll Cardiol 66:Suppl 1 (2015), B323–B324.
Rastan, A., McKinsey, J.F., Garcia, L.A., Rocha-Singh, K.J., Jaff, M.R., Noory, E., et al. One-year outcomes following directional atherectomy of infrapopliteal artery lesions: subgroup results of the prospective, multicenter DEFINITIVE LE trial. J Endovasc Ther 22 (2015), 839–846.
Yiu, W.K., Conte, M.S., Primary stenting in femoropopliteal occlusive disease—what is the appropriate role?. Circ J 79 (2015), 704–711.
Yiu, W.K., Conte, M.S., The roles of drug-eluting technology and atherectomy in infrapopliteal occlusive disease. Ital J Vasc Endovasc Surg 22 (2015), 1–2.
Mustapha, J.A., Finton, S.M., Diaz-Sandoval, L.J., Saab, F.A., Miller, L.E., Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis. Circ Cardiovasc Interv, 9, 2016, e003468.
Spreen, M.I., Martens, J.M., Hansen, B.E., Knippenberg, B., Verhey, E., van Dijk, L.C., et al. Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI)trial. Circ Cardiovasc Interv, 9, 2016, e002376.
Spreen, M.I., Martens, J.M., Knippenberg, B., van Dijk, L.C., de Vries, J.P., Vos, J.A., et al. Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia. J Am Heart Assoc, 6, 2017, e004877.
Guzman, R.J., Brinkley, D.M., Schumacher, P.M., Donahue, R.M., Beavers, H., Qin, X., Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol 51 (2008), 1967–1974.
Kang, I.S., Lee, W., Choi, B.W., Choi, D., Hong, M.K., Jang, Y., et al. Semiquantitative assessment of tibial artery calcification by computed tomography angiography and its ability to predict infrapopliteal angioplasty outcomes. J Vasc Surg 64 (2016), 1335–1343.
Kawarada, O., Fujihara, M., Higashimori, A., Yokoi, Y., Honda, Y., Fitzgerald, P.J., Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv 80 (2012), 861–871.
Haine, A., Haynes, A.G., Limacher, A., Sebastian, T., Saengprakai, W., Fuss, T., et al. Patency of the arterial pedal-plantar arch in patients with chronic kidney disease or diabetes mellitus. Ther Adv Cardiovasc Dis 12 (2018), 145–153.
Taylor, S.M., Kalbaugh, C.A., Blackhurst, D.W., Cass, A.L., Trent, E.A., Langan, E.M. 3rd, et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg 44 (2006), 747–755 discussion: 755-6.
Arvela, E., Söderström, M., Korhonen, M., Halmesmäki, K., Albäck, A., Lepäntalo, M., et al. Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia. J Vasc Surg 52 (2010), 1218–1225.
Moxey, P.W., Brownrigg, J., Kumar, S.S., Crate, G., Holt, P.J., Thompson, M.M., et al. The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores. J Vasc Surg 57 (2013), 1–7.
Simons, J.P., Schanzer, A., Flahive, J.M., Osborne, N.H., Mills, J.L. Sr., Bradbury, A.W., et al. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization. J Vasc Surg, 2018 Nov 26 [Epub ahead of print].
Kraiss, L.W., Beckstrom, J.L., Brooke, B.S., Frailty assessment in vascular surgery and its utility in preoperative decision making. Semin Vasc Surg 28 (2015), 141–147.
Kraiss, L.W., Al-Dulaimi, R., Presson, A.P., Arya, S., Lee, G.K., Goodney, P.P., et al. A Vascular Quality Initiative-based frailty instrument predicts 9-month postoperative mortality. J Vasc Surg 64 (2016), 551–552.
Kodama, A., Sugimoto, M., Kuma, S., Okazaki, J., Mii, S., Komori, K., Clinical outcomes after infrainguinal bypass grafting for critical limb ischaemia in patients with dialysis-dependent end-stage renal failure. Eur J Vasc Endovasc Surg 48 (2014), 695–702.
Fallon, J.M., Goodney, P.P., Stone, D.H., Patel, V.I., Nolan, B.W., Kalish, J.A., et al. Outcomes of lower extremity revascularization among the hemodialysis-dependent. J Vasc Surg 62 (2015), 1183–11891.e1.
Fleisher, L.A., Fleischmann, K.E., Auerbach, A.D., Barnason, S.A., Beckman, J.A., Bozkurt, B., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 64 (2014), e77–e137.
Kristensen, S.D., Knuuti, J., Saraste, A., Anker, S., Bøtker, H.E., Hert, S.D., et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC)and the European Society of Anaesthesiology (ESA). Eur Heart J 35 (2014), 2383–2431.
Pomposelli, F.B. Jr., Jepsen, S.J., Gibbons, G.W., Campbell, D.R., Freeman, D.V., Miller, A., et al. Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations. J Vasc Surg 11 (1990), 745–751 discussion: 751-2.
Eiberg, J.P., Hansen, M.A., Jorgensen, L.G., Rasmussen, J.B., Jensen, F., Schroeder, T.V., In-situ bypass surgery on arteriographically invisible vessels detected by Doppler-ultrasound for limb salvage. J Cardiovasc Surg (Torino)45 (2004), 375–379.
Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 51 (2010), 5S–17S.
Korhonen, M., Biancari, F., Söderström, M., Arvela, E., Halmesmäki, K., Albäck, A., et al. Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: a propensity score analysis. Eur J Vasc Endovasc Surg 41 (2011), 378–384.
Jones, W.S., Dolor, R.J., Hasselblad, V., Vemulapalli, S., Subherwal, S., Schmit, K., et al. Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia. Am Heart J 167 (2014), 489–498.e7.
Meltzer, A.J., Sedrakyan, A., Isaacs, A., Connolly, P.H., Schneider, D.B., Comparative effectiveness of peripheral vascular intervention versus surgical bypass for critical limb ischemia in the Vascular Study Group of Greater New York. J Vasc Surg 64 (2016), 1320–1326.e2.
Siracuse, J.J., Menard, M.T., Eslami, M.H., Kalish, J.A., Robinson, W.P., Eberhardt, R.T., et al. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative. J Vasc Surg 63 (2016), 958–965.e1.
Pomposelli, F.B., Kansal, N., Hamdan, A.D., Belfield, A., Sheahan, M., Campbell, D.R., et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 37 (2003), 307–315.
Dick, F., Diehm, N., Galimanis, A., Husmann, M., Schmidli, J., Baumgartner, I., Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg 45 (2007), 751–761.
Fernandez, N., McEnaney, R., Marone, L.K., Rhee, R.Y., Leers, S., Makaroun, M., et al. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia. J Vasc Surg 54 (2011), 722–729.
Antoniou, G.A., Chalmers, N., Georgiadis, G.S., Lazarides, M.K., Antoniou, S.A., Serracino-Inglott, F., et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 57 (2013), 242–253.
Baumann, F., Engelberger, R.P., Willenberg, T., Do, D.D., Kalka, C., Baumgartner, I., et al. Infrapopliteal lesion morphology in patients with critical limb ischemia: implications for the development of anti-restenosis technologies. J Endovasc Ther 20 (2013), 149–156.
Iida, O., Nakamura, M., Yamauchi, Y., Kawasaki, D., Yokoi, Y., Yokoi, H., et al. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv 6 (2013), 68–76.
Saqib, N.U., Domenick, N., Cho, J.S., Marone, L., Leers, S., Makaroun, M.S., et al. Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia. J Vasc Surg 57 (2013), 692–699.
Ballotta, E., Toniato, A., Piatto, G., Mazzalai, F., Da Giau, G., Lower extremity arterial reconstruction for critical limb ischemia in diabetes. J Vasc Surg 59 (2014), 708–719.
Iida, O., Nakamura, M., Yamauchi, Y., Fukunaga, M., Yokoi, Y., Yokoi, H., et al. 3-Year outcomes of the OLIVE registry, a prospective multicenter study of patients with critical limb ischemia: a prospective, multi-center, three-year follow-up study on endovascular treatment for infra-inguinal vessel in patients with critical limb ischemia. JACC Cardiovasc Interv 8 (2015), 1493–1502.
Brothers, T.E., Zhang, J., Mauldin, P.D., Tonnessen, B.H., Robison, J.G., Vallabhaneni, R., et al. Predicting outcomes for infrapopliteal limb-threatening ischemia using the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg 63 (2016), 114–124.e5.
Okamoto, S., Iida, O., Takahara, M., Yamauchi, Y., Hirano, K., Soga, Y., et al. Impact of perioperative complications after endovascular therapy in diabetic patients with critical limb ischemia due to isolated infrapopliteal lesions. J Endovasc Ther 23 (2016), 371–377.
Iida, O., Takahara, M., Soga, Y., Kodama, A., Terashi, H., Azuma, N., Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia). Circ Cardiovasc Interv, 10, 2017, e005531.
Nakama, T., Watanabe, N., Haraguchi, T., Sakamoto, H., Kamoi, D., Tsubakimoto, Y., et al. Clinical outcomes of pedal artery angioplasty for patients with ischemic wounds: results from the multicenter RENDEZVOUS registry. JACC Cardiovasc Interv 10 (2017), 79–90.
Vogel, T.R., Dombrovskiy, V.Y., Carson, J.L., Graham, A.M., In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia. J Vasc Surg 54 (2011), 109–115.
Nolan, B.W., De Martino, R.R., Stone, D.H., Schanzer, A., Goodney, P.P., Walsh, D.W., et al. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg 54 (2011), 730–735 discussion: 735-6.
Jones, D.W., Schanzer, A., Zhao, Y., MacKenzie, T.A., Nolan, B.W., Conte, M.S., et al. Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc, 2, 2013, e000345.
Faries, P.L., LoGerfo, F.W., Arora, S., Hook, S., Pulling, M.C., Akbari, C.M., et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 32 (2000), 1080–1090.
Brochado Neto, F., Sandri, G.A., Kalaf, M.J., Matielo, M.F., Casella, I.B., Godoy, M.R., et al. Arm vein as an alternative autogenous conduit for infragenicular bypass in the treatment of critical limb ischaemia: a 15 year experience. Eur J Vasc Endovasc Surg 47 (2014), 609–614.
Armstrong, P.A., Bandyk, D.F., Wilson, J.S., Shames, M.L., Johnson, B.L., Back, M.R., Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy. J Vasc Surg 40 (2004), 724–730 discussion: 730-1.
Taylor, G.I., Palmer, J.H., The vascular territories (angiosomes)of the body: experimental study and clinical applications. Br J Plast Surg 40 (1987), 113–141.
Attinger, C.E., Evans, K.K., Bulan, E., Blume, P., Cooper, P., Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg 117:Suppl (2006), 261S–293S.
Aerden, D., Denecker, N., Gallala, S., Debing, E., Van den Brande, P., Wound morphology and topography in the diabetic foot: hurdles in implementing angiosome-guided revascularization. Int J Vasc Med, 2014, 2014, 6.
Berceli, S.A., Chan, A.K., Pomposelli, F.B. Jr., Gibbons, G.W., Campbell, D.R., Akbari, C.M., et al. Efficacy of dorsal pedal artery bypass in limb salvage for ischemic heel ulcers. J Vasc Surg 30 (1999), 499–508.
Rashid, H., Slim, H., Zayed, H., Huang, D.Y., Wilkins, C.J., Evans, D.R., et al. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J Vasc Surg 57 (2013), 1219–1226.
Fusaro, M., Cassese, S., Ndrepepa, G., Tepe, G., King, L., Ott, I., et al. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials. JACC Cardiovasc Interv 6 (2013), 1284–1293.
Geraghty, P.J., Mewissen, M.W., Jaff, M.R., Ansel, G.M., VIBRANT Investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 58 (2013), 386–395.e4.
Todd, K.E., Ahanchi, S.S., Maurer, C.A., Kim, J.H., Chipman, C.R., Panneton, J.M., Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg 58 (2013), 941–948.
Ambler, G.K., Radwan, R., Hayes, P.D., Twine, C.P., Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev, 3, 2014, CD006680.
Antoniou, G.A., Georgakarakos, E.I., Antoniou, S.A., Georgiadis, G.S., Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?. Interact Cardiovasc Thorac Surg 19 (2014), 282–285.
Fanelli, F., Cannavale, A., Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era. Eur Radiol 24 (2014), 793–798.
Liu, X., Zheng, G., Wen, S., Drug-eluting stents versus control therapy in the infrapopliteal disease: a meta-analysis of eight randomized controlled trials and two cohort studies. Int J Surg 44 (2017), 166–175.
Gandini, R., Del Giudice, C., Simonetti, G., Pedal and plantar loop angioplasty: technique and results. J Cardiovasc Surg (Torino)55 (2014), 665–670.
Dorigo, W., Pulli, R., Castelli, P., Dorrucci, V., Ferilli, F., De Blasis, G., et al. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE)graft in the treatment of critical limb ischemia in diabetics. J Vasc Surg 54 (2011), 1332–1338.
Uhl, C., Grosch, C., Hock, C., Topel, I., Steinbauer, M., Comparison of long-term outcomes of heparin bonded polytetrafluoroethylene and autologous vein below knee femoropopliteal bypasses in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 54 (2017), 203–211.
Neville, R.F., Capone, A., Amdur, R., Lidsky, M., Babrowicz, J., Sidawy, A.N., A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia. J Vasc Surg 56 (2012), 1008–1014.
Cook, A.W., Oygar, A., Baggenstos, P., Pacheco, S., Kleriga, E., Vascular disease of extremities. Electric stimulation of spinal cord and posterior roots. N Y State J Med 76 (1976), 366–368.
Naoum, J.J., Arbid, E.J., Spinal cord stimulation for chronic limb ischemia. Methodist Debakey Cardiovasc J 9 (2013), 99–102.
Suy, R., Gybels, J., Van Damme, H., Martin, D., van Maele, R., Delaporte, C., (eds.)Spinal cord stimulation for ischemic rest pain. The Belgian randomized study, 1994, Steinkopff, Darmstadt.
Jivegard, L.E., Augustinsson, L.E., Holm, J., Risberg, B., Ortenwall, P., Effects of spinal cord stimulation (SCS)in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg 9 (1995), 421–425.
Claeys, L.G., Horsch, S., Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol 15 (1996), 344–349.
Ubbink, D.T., Spincemaille, G.H., Prins, M.H., Reneman, R.S., Jacobs, M.J., Dutch Spinal Cord Stimulation Study Group. Microcirculatory investigations to determine the effect of spinal cord stimulation for critical leg ischemia: the Dutch multicenter randomized controlled trial. J Vasc Surg 30 (1999), 236–244.
Spincemaille, G.H., Klomp, H.M., Steyerberg, E.W., Habbema, J.D., Spinal cord stimulation in patients with critical limb ischernia: a preliminary evaluation of a multicentre trial. Acta Chir Austriaca 32 (2000), 49–51.
Amann, W., Berg, P., Gersbach, P., Gamain, J., Raphael, J.H., Ubbink, D.T., Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 26 (2003), 280–286.
Klomp, H.M., Steyerberg, E.W., van Urk, H., Habbema, J.D., ESES Study Group. Spinal cord stimulation is not cost-effective for non-surgical management of critical limb ischaemia. Eur J Vasc Endovasc Surg 31 (2006), 500–508.
Sanni, A., Hamid, A., Dunning, J., Is sympathectomy of benefit in critical leg ischaemia not amenable to revascularisation?. Interact Cardiovasc Thorac Surg 4 (2005), 478–483.
Barnes, R.W., Baker, W.H., Shanik, G., Maixner, W., Hayes, A.C., Lin, R., et al. Value of concomitant sympathectomy in aortoiliac reconstruction. Results of a prospective, randomized study. Arch Surg 112 (1977), 1325–1330.
Cross, F.W., Cotton, L.T., Chemical lumbar sympathectomy for ischemic rest pain. A randomized, prospective controlled clinical trial. Am J Surg 150 (1985), 341–345.
Fyfe, T., Quin, R.O., Phenol sympathectomy in the treatment of intermittent claudication: a controlled clinical trail. Br J Surg 62 (1975), 68–71.
Kim, G.E., Ibrahim, I.M., Imparato, A.M., Lumbar sympathectomy in end stage arterial occlusive disease. Ann Surg 183 (1976), 157–160.
Collins, G.J. Jr., Rich, N.M., Clagett, G.P., Salander, J.M., Spebar, M.J., Clinical results of lumbar sympathectomy. Am Surg 47 (1981), 31–35.
Norman, P.E., House, A.K., The early use of operative lumbar sympathectomy in peripheral vascular disease. J Cardiovasc Surg (Torino)29 (1988), 717–722.
Baker, D.M., Lamerton, A.J., Operative lumbar sympathectomy for severe lower limb ischaemia: still a valuable treatment option. Ann R Coll Surg Engl 76 (1994), 50–53.
Alexander, J.P., Chemical lumbar sympathectomy in patients with severe lower limb ischaemia. Ulster Med J 63 (1994), 137–143.
Mashiah, A., Soroker, D., Pasik, S., Mashiah, T., Phenol lumbar sympathetic block in diabetic lower limb ischemia. J Cardiovasc Risk 2 (1995), 467–469.
Perez-Burkhardt, J.L., Gonzalez-Fajardo, J.A., Martin, J.F., Carpintero Mediavilla, L.A., Mateo Gutierrez, A.M., Lumbar sympathectomy as isolated technique for the treatment of lower limbs chronic ischemia. J Cardiovasc Surg (Torino)40 (1999), 7–13.
Holiday, F.A., Barendregt, W.B., Slappendel, R., Crul, B.J., Buskens, F.G., van der Vliet, J.A., Lumbar sympathectomy in critical limb ischaemia: surgical, chemical or not at all?. Cardiovasc Surg 7 (1999), 200–202.
Matarazzo, A., Rosati Tarulli, V., Sassi, O., Florio, A., Tatafiore, M., Molino, C., Possibilities at present for the application of lumbar sympathectomy in chronic occlusive arterial disease of the lower limbs. Minerva Cardioangiol 50 (2002), 363–369.
Pieri, S., Agresti, P., Ialongo, P., Fedeli, S., Di Cesare, F., Ricci, G., Lumbar sympathectomy under CT guidance: therapeutic option in critical limb ischaemia. Radiol Med 109 (2005), 430–437.
Moran, P.S., Teljeur, C., Harrington, P., Ryan, M., A systematic review of intermittent pneumatic compression for critical limb ischaemia. Vasc Med 20 (2015), 41–50.
Labropoulos, N., Wierks, C., Suffoletto, B., Intermittent pneumatic compression for the treatment of lower extremity arterial disease: a systematic review. Vasc Med 7 (2002), 141–148.
Kavros, S.J., Delis, K.T., Turner, N.S., Voll, A.E., Liedl, D.A., Gloviczki, P., et al. Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg 47 (2008), 543–549.
Tawfick, W.A., Hamada, N., Soylu, E., Fahy, A., Hynes, N., Sultan, S., Sequential compression biomechanical device versus primary amputation in patients with critical limb ischemia. Vasc Endovascular Surg 47 (2013), 532–539.
Dillon, R.S., Treatment of resistant venous stasis ulcers and dermatitis with the end-diastolic pneumatic compression boot. Angiology 37 (1986), 47–56.
Dillon, R.S., Successful treatment of osteomyelitis and soft tissue infections in ischemic diabetic legs by local antibiotic injections and the end-diastolic pneumatic compression boot. Ann Surg 204 (1986), 643–649.
Steinberg, J., Cardiosynchronous limb compression: effects on noninvasive vascular tests and clinical course of the ischemic limb. Angiology 43 (1992), 453–461.
van Bemmelen, P.S., Gitlitz, D.B., Faruqi, R.M., Weiss-Olmanni, J., Brunetti, V.A., Giron, F., et al. Limb salvage using high-pressure intermittent compression arterial assist device in cases unsuitable for surgical revascularization. Arch Surg 136 (2001), 1280–1285.
Louridas, G., Saadia, R., Spelay, J., Abdoh, A., Weighell, W., Arneja, A.S., et al. The ArtAssist Device in chronic lower limb ischemia. A pilot study. Int Angiol 21 (2002), 28–35.
Montori, V.M., Kavros, S.J., Walsh, E.E., Rooke, T.W., Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Clinic experience (1998-2000). Int Angiol 21 (2002), 360–366.
Sultan, S., Hamada, N., Soylu, E., Fahy, A., Hynes, N., Tawfick, W., Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease. J Vasc Surg 54 (2011), 440–446 discussion: 446-7.
Chang, S.T., Hsu, J.T., Chu, C.M., Pan, K.L., Jang, S.J., Lin, P.C., et al. Using intermittent pneumatic compression therapy to improve quality of life for symptomatic patients with infrapopliteal diffuse peripheral obstructive disease. Circ J 76 (2012), 971–976.
Setacci, C., de Donato, G., Teraa, M., Moll, F.L., Ricco, J.B., Becker, F., et al. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 42:Suppl 2 (2011), S43–S59.
Ruffolo, A.J., Romano, M., Ciapponi, A., Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev, 1, 2010, CD006544.
Lambert, M.A., Belch, J.J., Medical management of critical limb ischaemia: where do we stand today?. J Intern Med 274 (2013), 295–307.
Creutzig, A., Lehmacher, W., Elze, M., Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV. Vasa 33 (2004), 137–144.
Loosemore, T.M., Chalmers, T.C., Dormandy, J.A., A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. Int Angiol 13 (1994), 133–142.
Belch, J.J., Ray, S., Rajput-Ray, M., Engeset, J., Fagrell, B., Lepantalo, M., et al. The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia. Int Angiol 30 (2011), 150–155.
Intravenous pentoxifylline for the treatment of chronic critical limb ischaemia. The European Study Group. Eur J Vasc Endovasc Surg 9 (1995), 426–436.
Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia. A placebo controlled multicenter study. Norwegian Pentoxifylline Multicenter Trial Group. Int Angiol 15 (1996), 75–80.
Miyashita, Y., Saito, S., Miyamoto, A., Iida, O., Nanto, S., Cilostazol increases skin perfusion pressure in severely ischemic limbs. Angiology 62 (2011), 15–17.
Soga, Y., Iida, O., Hirano, K., Suzuki, K., Kawasaki, D., Miyashita, Y., et al. Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia. J Vasc Surg 54 (2011), 1659–1667.
Tonnesen, K.H., Sager, P., Gormsen, J., Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study. Scand J Clin Lab Invest 38 (1978), 431–435.
Lowe, G.D., Dunlop, D.J., Lawson, D.H., Pollock, J.G., Watt, J.K., Forbes, C.D., et al. Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg. Angiology 33 (1982), 46–50.
Stoekenbroek, R.M., Santema, T.B., Legemate, D.A., Ubbink, D.T., van den Brink, A., Koelemay, M.J., Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. Eur J Vasc Endovasc Surg 47 (2014), 647–655.
Murad, M.H., Altayar, O., Bennett, M., Wei, J.C., Claus, P.L., Asi, N., et al. Using GRADE for evaluating the quality of evidence in hyperbaric oxygen therapy clarifies evidence limitations. J Clin Epidemiol 67 (2014), 65–72.
Faglia, E., Favales, F., Aldeghi, A., Calia, P., Quarantiello, A., Oriani, G., et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes Care 19 (1996), 1338–1343.
Abidia, A., Laden, G., Kuhan, G., Johnson, B.F., Wilkinson, A.R., Renwick, P.M., et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 25 (2003), 513–518.
Löndahl, M., Katzman, P., Nilsson, A., Hammarlund, C., Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 33 (2010), 998–1003.
Löndahl, M., Katzman, P., Hammarlund, C., Nilsson, A., Landin-Olsson, M., Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. Diabetologia 54 (2011), 65–68.
Margolis, D.J., Gupta, J., Hoffstad, O., Papdopoulos, M., Glick, H.A., Thom, S.R., et al. Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study. Diabetes Care 36 (2013), 1961–1966.
Anderson, J.L., Halperin, J.L., Albert, N.M., Bozkurt, B., Brindis, R.G., Curtis, L.H., et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127 (2013), 1425–1443.
Lepantalo, M., Matzke, S., Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 11 (1996), 153–157.
Slovut, D.P., Sullivan, T.M., Critical limb ischemia: medical and surgical management. Vasc Med 13 (2008), 281–291.
Elgzyri, T., Larsson, J., Thorne, J., Eriksson, K.F., Apelqvist, J., Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg 46 (2013), 110–117.
Nesargikar, P.N., Ajit, M.K., Eyers, P.S., Nichols, B.J., Chester, J.F., Lumbar chemical sympathectomy in peripheral vascular disease: does it still have a role?. Int J Surg 7 (2009), 145–149.
Martini, R., Andreozzi, G.M., Deri, A., Cordova, R., Zulian, P., Scarpazza, O., et al. Amputation rate and mortality in elderly patients with critical limb ischemia not suitable for revascularization. Aging Clin Exp Res 24:Suppl (2012), 24–27.
Isner, J.M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348 (1996), 370–374.
Nikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visona, A., Capogrossi, M.C., et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 16 (2008), 972–978.
Baumgartner, I., Chronos, N., Comerota, A., Henry, T., Pasquet, J.P., Finiels, F., et al. Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia. Mol Ther 17 (2009), 914–921.
Belch, J., Hiatt, W.R., Baumgartner, I., Driver, I.V., Nikol, S., Norgren, L., et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 377 (2011), 1929–1937.
Powell, R.J., Goodney, P., Mendelsohn, F.O., Moen, E.K., Annex, B.H., Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial. J Vasc Surg 52 (2010), 1525–1530.
Powell, R.J., Simons, M., Mendelsohn, F.O., Daniel, G., Henry, T.D., Koga, M., et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 118 (2008), 58–65.
Shigematsu, H., Yasuda, K., Iwai, T., Sasajima, T., Ishimaru, S., Ohashi, Y., et al. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther 17 (2010), 1152–1161.
Iafrati, M.D., Hallett, J.W., Geils, G., Pearl, G., Lumsden, A., Peden, E., et al. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg 54 (2011), 1650–1658.
Murphy, M.P., Lawson, J.H., Rapp, B.M., Dalsing, M.C., Klein, J., Wilson, M.G., et al. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg 53 (2011), 1565–15674.e1.
Iafrati, M.D., O'Donnell, T.F. Jr., Perler, B., Illig, K.A., Hallett, J., Woo, K., et al. SS03. Bone marrow aspirate concentrate in critical limb ischemia: results of an abridged prospective randomized pivotal trial in no option CLI. J Vasc Surg, 63, 2016, 47S.
Murphy, M., Ross, C., Kibbe, M., Kelso, R., Sharafuddin, M., Tzeng, E., et al. Administration of autologous bone marrow cells for limb salvage in patients with critical limb ischemia: results of the multicenter phase III MOBILE trial. Nov 12-16, 2016, American Heart Association Scientific Sessions, New Orleans, La.
Powell, R.J., Marston, W.A., Berceli, S.A., Guzman, R., Henry, T.D., Longcore, A.T., et al. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. Mol Ther 20 (2012), 1280–1286.
Losordo, D.W., Kibbe, M.R., Mendelsohn, F., Marston, W., Driver, V.R., Sharafuddin, M., et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv 5 (2012), 821–830.
Pignon, B., Sevestre, M.A., Kanagaratnam, L., Pernod, G., Stephan, D., Emmerich, J., et al. Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia—results of a randomized, double-blind, placebo-controlled trial. Circ J 81 (2017), 1713–1720.
Teraa, M., Sprengers, R.W., Schutgens, R.E., Slaper-Cortenbach, I.C., van der Graaf, Y., Algra, A., et al. Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS)trial. Circulation 131 (2015), 851–860.
Thom, S.R., Hampton, M., Troiano, M.A., Mirza, Z., Malay, D.S., Shannon, S., et al. Measurements of CD34+/CD45-dim stem cells predict healing of diabetic neuropathic wounds. Diabetes 65 (2016), 86–97.
Sheahan, M.G., Hamdan, A.D., Veraldi, J.R., McArthur, C.S., Skillman, J.J., Campbell, D.R., et al. Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization. J Vasc Surg 42 (2005), 476–480.
Kadukammakal, J., Yau, S., Urbas, W., Assessment of partial first-ray resections and their tendency to progress to transmetatarsal amputations. J Am Podiatr Med Assoc 102 (2012), 412–416.
Borkosky, S.L., Roukis, T.S., Incidence of repeat amputation after partial first ray amputation associated with diabetes mellitus and peripheral neuropathy: an 11-year review. J Foot Ankle Surg 52 (2013), 335–338.
Thorud, J.C., Jupiter, D.C., Lorenzana, J., Nguyen, T.T., Shibuya, N., Reoperation and reamputation after transmetatarsal amputation: a systematic review and meta-analysis. J Foot Ankle Surg 55 (2016), 1007–1012.
Lavery, L.A., Lavery, D.C., Quebedeax-Farnham, T.L., Increased foot pressures after great toe amputation in diabetes. Diabetes Care 18 (1995), 1460–1462.
Ballotta, E., Da Giau, G., Gruppo, M., Mazzalai, F., Martella, B., Militello, C., et al. Revascularization to an isolated (blind)popliteal artery segment: a viable procedure for critical limb ischemia. Surgery 145 (2009), 426–434.
Mohapatra, A., Henry, J.C., Avgerinos, E.D., Chaer, R.A., Leers, S.A., Boitet, A., et al. Heel wounds predict mortality but not amputation after infrapopliteal revascularization. Ann Vasc Surg 51 (2018), 78–85.
Oliver, N.G., Steinberg, J.S., Powers, K., Evans, K.K., Kim, P.J., Attinger, C.E., Lower extremity function following partial calcanectomy in high-risk limb salvage patients. J Diabetes Res, 2015, 2015, 7.
Kodama, A., Koyama, A., Sugimoto, M., Niimi, K., Banno, H., Komori, K., Association between preoperative frailty and mortality in patients with critical limb ischemia following infrainguinal bypass surgery—usefulness of the Barthel index. Circ J 82 (2017), 267–274.
Chopra, A., Azarbal, A.F., Jung, E., Abraham, C.Z., Liem, T.K., Landry, G.J., et al. Ambulation and functional outcome after major lower extremity amputation. J Vasc Surg 67 (2018), 1521–1529.
Arsenault, K.A., Al-Otaibi, A., Devereaux, P.J., Thorlund, K., Tittley, J.G., Whitlock, R.P., The use of transcutaneous oximetry to predict healing complications of lower limb amputations: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 43 (2012), 329–336.
Dillingham, T.R., Pezzin, L.E., Shore, A.D., Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil 86 (2005), 480–486.
Kono, Y., Muder, R.R., Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation. Ann Vasc Surg 26 (2012), 1120–1126.
Beaulieu, R.J., Grimm, J.C., Lyu, H., Abularrage, C.J., Perler, B.A., Rates and predictors of readmission after minor lower extremity amputations. J Vasc Surg 62 (2015), 101–105.
Landry, G.J., Silverman, D.A., Liem, T.K., Mitchell, E.L., Moneta, G.L., Predictors of healing and functional outcome following transmetatarsal amputations. Arch Surg 146 (2011), 1005–1009.
Quigley, M., Dillon, M.P., Quality of life in persons with partial foot or transtibial amputation: a systematic review. Prosthet Orthot Int 40 (2016), 18–30.
O'Brien, P.J., Cox, M.W., Shortell, C.K., Scarborough, J.E., Risk factors for early failure of surgical amputations: an analysis of 8,878 isolated lower extremity amputation procedures. J Am Coll Surg 216 (2013), 836–842.
Waton, S., Johal, A., Heikkila, K., Cromwell, D., Loftus, I., National Vascular Registry: 2015 annual report. November 2015, The Royal College of Surgeons of England, London.
van Netten, J.J., Fortington, L.V., Hinchliffe, R.J., Hijmans, J.M., Early post-operative mortality after major lower limb amputation: a systematic review of population and regional based studies. Eur J Vasc Endovasc Surg 51 (2016), 248–257.
Uzzaman, M.M., Jukaku, S., Kambal, A., Hussain, S.T., Assessing the long-term outcomes of minor lower limb amputations: a 5-year study. Angiology 62 (2011), 365–371.
Wilbek, T.E., Jansen, R.B., Jørgensen, B., Svendsen, O.L., The diabetic foot in a multidisciplinary team setting. Number of amputations below ankle level and mortality. Exp Clin Endocrinol Diabetes 124 (2016), 535–540.
Subramaniam, B., Pomposelli, F., Talmor, D., Park, K.W., Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics. Anesth Analg 100 (2005), 1241–1247.
Fortington, L.V., Geertzen, J.H., van Netten, J.J., Postema, K., Rommers, G.M., Dijkstra, P.U., Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg 46 (2013), 124–131.
Inderbitzi, R., Buettiker, M., Enzler, M., The long-term mobility and mortality of patients with peripheral arterial disease following bilateral amputation. Eur J Vasc Endovasc Surg 26 (2003), 59–64.
Hoffmann, M., Kujath, P., Flemming, A., Proß, M., Begum, N., Zimmermann, M., et al. Survival of diabetes patients with major amputation is comparable to malignant disease. Diab Vasc Dis Res 12 (2015), 265–271.
The Vascular Society of Great Britain and Ireland quality improvement framework for major amputation surgery. A best practice clinical care pathway for major amputation surgery. Available at: https://www.vascularsociety.org.uk/_userfiles/pages/files/Resources/Vasc_Soc_Amputation_Paper_V2.pdf Accessed March 2017.
Karam, J., Shepard, A., Rubinfeld, I., Predictors of operative mortality following major lower extremity amputations using the National Surgical Quality Improvement Program public use data. J Vasc Surg 58 (2013), 1276–1282.
Fisher, S.V., Gullickson, G. Jr., Energy cost of ambulation in health and disability: a literature review. Arch Phys Med Rehabil 59 (1978), 124–133.
Ali, M.M., Loretz, L., Shea, A., Poorvu, E., Robinson, W.P., Schanzer, A., et al. A contemporary comparative analysis of immediate postoperative prosthesis placement following below-knee amputation. Ann Vasc Surg 27 (2013), 1146–1153.
National Confidential Enquiry into Patient Outcome and Death. Lower limb amputation: working together. Available at: http://www.ncepod.org.uk/2014report2/downloads/WorkingTogetherFullReport.pdf Accessed March 2017.
Mehta, S.R., Yusuf, S., Peters, R.J., Bertrand, M.E., Lewis, B.S., Natarajan, M.K., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001), 527–533.
Steinhubl, S.R., Berger, P.B., Mann, I.J., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002), 2411–2420.
Nguyen, T.A., Diodati, J.G., Pharand, C., Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 45 (2005), 1157–1164.
Dörffler-Melly, J., Koopman, M.M., Prins, M.H., Büller, H.R., Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev, 1, 2005, CD002071.
Soden, P.A., Zettervall, S.L., Ultee, K.H., Landon, B.E., O'Malley, A.J., Goodney, P.P., et al. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization. J Vasc Surg 64 (2016), 1633–16344.e1.
Iida, O., Yokoi, H., Soga, Y., Inoue, N., Suzuki, K., Yokoi, Y., et al. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation 127 (2013), 2307–2315.
Iftikhar, O., Oliveros, K., Tafur, A.J., Casanegra, A.I., Prevention of femoropopliteal in-stent restenosis with cilostazol: a meta-analysis. Angiology 67 (2016), 549–555.
Soga, Y., Takahara, M., Iida, O., Yamauchi, Y., Hirano, K., Fukunaga, M., et al. Efficacy of CilostAzol for Below-the-Knee Artery Disease after Balloon AnGioplasty in PatiEnts with Severe Limb Ischemia (CABBAGE Trial). Ann Vasc Surg 45 (2017), 22–28.
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 355 (2000), 346–351.
Johnson, W.C., Williford, W.O., Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg 35 (2002), 413–421.
Sarac, T.P., Huber, T.S., Back, M.R., Ozaki, C.K., Carlton, L.M., Flynn, T.C., et al. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 28 (1998), 446–457.
Geraghty, A.J., Welch, K., Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst Rev, 6, 2011, CD000536.
Brumberg, R.S., Back, M.R., Armstrong, P.A., Cuthbertson, D., Shames, M.L., Johnson, B.L., et al. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg 46 (2007), 1160–1166.
Mewissen, M.W., Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol 7 (2004), 2–5.
Duda, S.H., Bosiers, M., Lammer, J., Scheinert, D., Zeller, T., Oliva, V., et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13 (2006), 701–710.
Schillinger, M., Sabeti, S., Dick, P., Amighi, J., Mlekusch, W., Schlager, O., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007), 2745–2749.
Laird, J.R., Jain, A., Zeller, T., Feldman, R., Scheinert, D., Popma, J.J., et al. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the Complete SE Multicenter Trial. J Endovasc Ther 21 (2014), 202–212.
Idu, M.M., Blankstein, J.D., de Gier, P., Truyen, E., Buth, J., Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience. J Vasc Surg 17 (1993), 42–53.
Lundell, A., Lindblad, B., Bergqvist, D., Hansen, F., Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg 21 (1995), 26–34.
Ihlberg, L., Luther, M., Tierala, E., Lepantalo, M., The utility of duplex scanning in infrainguinal vein graft surveillance: results from a randomised controlled study. Eur J Vasc Endovasc Surg 16 (1998), 19–27.
Ihlberg, L., Luther, M., Alback, A., Kantonen, I., Lepantalo, M., Does a completely accomplished duplex-based surveillance prevent vein-graft failure?. Eur J Vasc Endovasc Surg 18 (1999), 395–400.
Bandyk, D.F., Infrainguinal vein bypass graft surveillance: how to do it, when to intervene, and is it cost-effective?. J Am Coll Surg 194 (2002), S40–S52.
Davies, A.H., Hawdon, A.J., Sydes, M.R., Thompson, S.G., Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation 112 (2005), 1985–1991.
Baril, D.T., Rhee, R.Y., Kim, J., Makaroun, M.S., Chaer, R.A., Marone, L.K., Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery. J Vasc Surg 49 (2009), 133–139.
Saarinen, E., Laukontaus, S.J., Albäck, A., Venermo, M., Duplex surveillance after endovascular revascularisation for critical limb ischaemia. Eur J Vasc Endovasc Surg 47 (2014), 418–421.
Armstrong, P.A., Bandyk, D.F., Surveillance after peripheral artery angioplasty and stenting. Zierler, E., (eds.)Strandness's duplex scanning in vascular disorders, 4th ed., 2010, Lippincott Williams & Wilkins, Philadelphia, 169–176.
Baril, D.T., Marone, L.K., Rationale and benefits of surveillance after percutaneous transluminal angioplasty and stenting of iliac and femoral arteries. AbuRahma, A.F., Bandyk, D.F., (eds.)Noninvasive vascular diagnosis: a practical guide to therapy, 2013, Springer, London, 339–346.
Mewissen, M.W., Kinney, E.V., Bandyk, D.F., Reifsnyder, T., Seabrook, G.R., Lipchik, E.O., et al. The role of duplex scanning versus angiography in predicting outcome after balloon angioplasty in the femoropopliteal artery. J Vasc Surg 15 (1992), 860–865.
Spijkerboer, A.M., Nass, P.C., de Valois, J.C., van der Graaf, Y., Eikelboom, B.C., Mali, W.P., Evaluation of femoropopliteal arteries with duplex ultrasound after angioplasty. Can we predict results at one year?. Eur J Vasc Endovasc Surg 12 (1996), 418–423.
Kasirajan, K., Gray, B., Beavers, F.P., Clair, D.G., Greenberg, R., Mascha, E., et al. Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Radiol 12 (2001), 413–421.
Sarac, T.P., Hilleman, D., Arko, F.R., Zarins, C.K., Ouriel, K., Clinical and economic evaluation of the Trellis thrombectomy device for arterial occlusions: preliminary analysis. J Vasc Surg 39 (2004), 556–559.
Sacks, D., Robinson, M.L., Summers, T.A., Marinelli, D.L., The value of duplex sonography after peripheral artery angioplasty in predicting subacute restenosis. AJR Am J Roentgenol 162 (1994), 179–183.
Tielbeek, A.V., Rietjens, E., Buth, J., Vroegindeweij, D., Schol, F.P., The value of duplex surveillance after endovascular intervention for femoropopliteal obstructive disease. Eur J Vasc Endovasc Surg 12 (1996), 145–150.
Mills, J.L., Bandyk, D.F., Gahtan, V., Esses, G.E., The origin of infrainguinal vein graft stenosis: a prospective study based on duplex surveillance. J Vasc Surg 21 (1995), 16–25.
Avino, A.J., Bandyk, D.F., Gonsalves, A.J., Johnson, B.L., Black, T.J., Zwiebel, B.R., et al. Surgical and endovascular intervention for infrainguinal vein graft stenosis. J Vasc Surg 29 (1999), 60–71.
Abu Dabrh, A.M., Mohammed, K., Farah, W., Haydour, Q., Zierler, R.E., Wang, Z., et al. Systematic review and meta-analysis of duplex ultrasound surveillance for infrainguinal vein bypass grafts. J Vasc Surg 66 (2017), 1885–1891.e8.
Björkman, P., Peltola, E., Albäck, A., Venermo, M., Peripheral vascular restenosis: a retrospective study on the use of drug-eluting balloons in native arteries, vein grafts and dialysis accesses. Scand J Surg 106 (2017), 158–164.
Jongsma, H., Akkersdijk, G.P., de Smet, A., Vroegindeweij, D., de Vries, J.P.M., Fioole, B., Drug-eluting balloons and uncoated balloons perform equally to rescue infrainguinal autologous bypasses at risk. J Vasc Surg 66 (2017), 454–460.
Dunlop, P., Sayers, R.D., Naylor, A.R., Bell, P.R., London, N.J., The effect of a surveillance programme on the patency of synthetic infrainguinal bypass grafts. Eur J Vasc Endovasc Surg 11 (1996), 441–445.
Aune, S., Pedersen, O.M., Trippestad, A., Surveillance of above-knee prosthetic femoropopliteal bypass. Eur J Vasc Endovasc Surg 16 (1998), 509–512.
Calligaro, K.D., Doerr, K., McAffee-Bennett, S., Krug, R., Raviola, C.A., Dougherty, M.J., Should duplex ultrasonography be performed for surveillance of femoropopliteal and femorotibial arterial prosthetic bypasses?. Ann Vasc Surg 15 (2001), 520–524.
Mohler, E.R., Gornik, H.L., Gerhard-Herman, M., Misra, S., Olin, J.W., Zierler, R.E., ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol 60 (2012), 242–276.
Stone, P.A., Armstrong, P.A., Bandyk, D.F., Keeling, W.B., Flaherty, S.K., Shames, M.L., et al. Duplex ultrasound criteria for femorofemoral bypass revision. J Vasc Surg 44 (2006), 496–502.
Fitzgerald, R.H., Mills, J.L., Joseph, W., Armstrong, D.G., The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage. Eplasty, 9, 2009, e15.
Rogers, L.C., Andros, G., Caporusso, J., Harkless, L.B., Mills, J.L. Sr., Armstrong, D.G., Toe and flow: essential components and structure of the amputation prevention team. J Vasc Surg 52 (2010), 23S–27S.
Armstrong, D.G., Mills, J.L., Juggling risk to reduce amputations: the three-ring circus of infection, ischemia and tissue loss-dominant conditions. Wound Med 1 (2013), 13–14.
Pickwell, K.M., Siersma, V.D., Kars, M., Holstein, P.E., Schaper, N.C., Diabetic foot disease: impact of ulcer location on ulcer healing. Diabetes Metab Res Rev 29 (2013), 377–383.
Armstrong, D.G., Lavery, L.A., Nixon, B.P., Boulton, A.J., It's not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. Clin Infect Dis 39:Suppl 2 (2004), S92–S99.
Bus, S.A., Armstrong, D.G., van Deursen, R.W., Lewis, J., Caravaggi, C.F., Cavanagh, P.R., IWGDF Guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. Available at: www.iwgdf.org/files/2015/website_footwearoffloading.pdf. (Accessed 30 October 2018)
Pappalardo, J., Plemmons, B., Armstrong, D., Wound healing simplification: a vertical and horizontal philosophy illustrated. J Wound Technol 19 (2013), 38–39.
Rose, J.F., Giovinco, N., Mills, J.L., Najafi, B., Pappalardo, J., Armstrong, D.G., Split-thickness skin grafting the high-risk diabetic foot. J Vasc Surg 59 (2014), 1657–1663.
Armstrong, D.G., Boulton, A.J., Bus, S.A., Diabetic foot ulcers and their recurrence. N Engl J Med 376 (2017), 2367–2375.
Armstrong, D.G., Lavery, L.A., Frykberg, R.G., Wu, S.C., Boulton, A.J., Validation of a diabetic foot surgery classification. Int Wound J 3 (2006), 240–246.
Armstrong, D.G., Holtz-Neiderer, K., Wendel, C., Mohler, M.J., Kimbriel, H.R., Lavery, L.A., Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med 120 (2007), 1042–1046.
Arad, Y., Fonseca, V., Peters, A., Vinik, A., Beyond the monofilament for the insensate diabetic foot. A systematic review of randomized trials to prevent the occurrence of plantar foot ulcers in patients with diabetes. Diabetes Care 34 (2011), 1041–1046.
Ulbrecht, J.S., Hurley, T., Mauger, D.T., Cavanagh, P.R., Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial. Diabetes Care 37 (2014), 1982–1989.
Cook, J.A., McCulloch, P., Blazeby, J.M., Beard, D.J., Marinac-Dabic, D., Sedrakyan, A., IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ, 346, 2013.
Ergina, P.L., Barkun, J.S., McCulloch, P., Cook, J.A., Altman, D.G., IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages. BMJ : British Medical Journal, 346, 2013, f2820.
Hirst, A., Philippou, Y., Blazeby, J., Campbell, B., Campbell, M., Feinberg, J., et al. No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations. Ann Surg 269 (2019), 211–220.
McCulloch, P., Cook, J.A., Altman, D.G., Heneghan, C., Diener, M.K., IDEAL framework for surgical innovation 1: the idea and development stages. BMJ, 346, 2013, f3012.
Sedrakyan, A., Campbell, B., Merino, J.G., Kuntz, R., Hirst, A., McCulloch, P., IDEAL-D: a rational framework for evaluating and regulating the use of medical devices. BMJ, 353, 2016, i2372.
Behrendt, C.A., Bertges, D., Eldrup, N., Beck, A.W., Mani, K., Venermo, M., et al. International Consortium of Vascular Registries consensus recommendations for peripheral revascularisation registry data collection. Eur J Vasc Endovasc Surg 56 (2018), 217–237.
Bhatt, D.L., Mehta, C., Adaptive designs for clinical trials. N Engl J Med 375 (2016), 65–74.
Bothwell, L.E., Podolsky, S.H., The emergence of the randomized, controlled trial. N Engl J Med 375 (2016), 501–504.
Avery, K.N., Williamson, P.R., Gamble, C., O'Connell Francischetto, E., Metcalfe, C., Davidson, P., et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open, 7, 2017, e013537.
Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)trial. Health Technol Assess 14 (2010), 1–210, iii-iv.
Nordanstig, J., Wann-Hansson, C., Karlsson, J., Lundström, M., Pettersson, M., Morgan, M.B., Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease. J Vasc Surg 59 (2014), 700–707.e1.
Conte, M.S., Bandyk, D.F., Clowes, A.W., Moneta, G.L., Seely, L., Lorenz, T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006), 742–751.e1.
Clark, T.G., Altman, D.G., Stavola, B.L., Quantification of the completeness of follow-up. Lancet 359 (2002), 1309–1310.
Clark, T.G., Bradburn, M.J., Love, S.B., Altman, D.G., Survival analysis part I: basic concepts and first analyses. Br J Cancer, 89, 2003, 232.
von Allmen, R.S., Weiss, S., Tevaearai, H.T., Kuemmerli, C., Tinner, C., Carrel, T.P., et al. Completeness of follow-up determines validity of study findings: results of a prospective repeated measures cohort study. PLoS One, 10, 2015, e0140817.
Grading of Recommendations Assessment, Development, and Evaluation (GRADE)working group. Available at: www.gradeworkinggroup.org. (Accessed 30 October 2018)
Conte, M.S., Farber, A., Revascularization for chronic limb-threatening ischaemia. Br J Surg 102 (2015), 1007–1009.
Caro, J., Migliaccio-Walle, K., Ishak, K.J., Proskorovsky, I., The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord, 5, 2005, 14.
Carls, G.S., Gibson, T.B., Driver, V.R., Wrobel, J.S., Garoufalis, M.G., DeFrancis, R.R., et al. The economic value of specialized lower-extremity medical care by podiatric physicians in the treatment of diabetic foot ulcers. J Am Podiatr Med Assoc 101 (2011), 93–115.
Chan, B., Cadarette, S., Wodchis, W., Wong, J., Mittmann, N., Krahn, M., Cost-of-illness studies in chronic ulcers: a systematic review. J Wound Care 26:Suppl 4 (2017), S4–S14.
Stockl, K., Vanderplas, A., Tafesse, E., Chang, E., Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care 27 (2004), 2129–2134.
Centers for Disease Control and Prevention. United States hospital discharge data, 2012. Available at: https://www.cdc.gov/nchs/nhds/ Accessed October 30, 2018.
Skrepnek, G.H., Mills, J.L., Lavery, L.A., Armstrong, D.G., Health care service and outcomes among an estimated 6.7 million ambulatory care diabetic foot cases in the U.S. Diabetes Care 40 (2017), 936–942.
Ü, Gök, Selek, Ö., Selek, A., Güdük, A., Güner, M.Ç., Survival evaluation of the patients with diabetic major lower-extremity amputations. Musculoskelet Surg 100 (2016), 145–148.
Robbins, J.M., Strauss, G., Aron, D., Long, J., Kuba, J., Kaplan, Y., Mortality rates and diabetic foot ulcers. J Am Podiatr Med Assoc 98 (2008), 489–493.
Sugerman, D., Centers of excellence. JAMA, 310, 2013, 994.
Rogers, L.C., Andros, G., Caporusso, J., Harkless, L.B., Mills, J.L. Sr., Armstrong, D.G., Toe and flow. J Am Podiatr Med Assoc 100 (2010), 342–348.
Rogers, L.C., Armstrong, D.G., Podiatry care. Cronenwett, J.L., Johnston, K.W., (eds.)Rutherford's vascular surgery, 7th ed., 2010, Saunders Elsevier, Philadelphia, 1747–1760.
Reiber, G.E., Vileikyte, L., Boyko, E.J., del Aguila, M., Smith, D.G., Lavery, L.A., et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22 (1999), 157–162.
Pecoraro, R.E., Reiber, G.E., Burgess, E.M., Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13 (1990), 513–521.
Rogers, L.C., Frykberg, R.G., Armstrong, D.G., Boulton, A.J., Edmonds, M., Van, G.H., et al. The Charcot foot in diabetes. J Am Podiatr Med Assoc 101 (2011), 437–446.
Wukich, D.K., Armstrong, D.G., Attinger, C.E., Boulton, A.J., Burns, P.R., Frykberg, R.G., et al. Inpatient management of diabetic foot disorders: a clinical guide. Diabetes Care 36 (2013), 2862–2871.
Snyder, R.J., Frykberg, R.G., Rogers, L.C., Applewhite, A.J., Bell, D., Bohn, G., et al. The management of diabetic foot ulcers through optimal off-loading. J Am Podiatr Med Assoc 104 (2014), 555–567.
Hingorani, A., LaMuraglia, G.M., Henke, P., Meissner, M.H., Loretz, L., Zinszer, K.M., et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 63:Suppl (2016), 3S–21S.
National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. Available at: https://www.nice.org.uk/guidance/ng19. (Accessed 30 October 2018)
World Union of Wound Healing Societies, Position Document. Local management of diabetic foot ulcers. Available at: http://www.wuwhs2016.com/files/WUWHS_DFUs_web.pdf. (Accessed 30 October 2018)
Wrobel, J.S., Robbins, J., Armstrong, D.G., The high-low amputation ratio: a deeper insight into diabetic foot care?. J Foot Ankle Surg 45 (2006), 375–379.
International Diabetes Federation. The diabetic foot: amputations are preventable. Available at: http://www.idf.org/Position_statementsdiabetic_foot. (Accessed 30 July 2008)
World Health Organization. World Diabetes Day: too many people are losing lower limbs unnecessarily to diabetes [press release]. Available at: https://www.who.int/mediacentre/news/releases/2005/pr61/en/. (Accessed 30 July 2008)
Sanders, L.J., Robbins, J.M., Edmonds, M.E., History of the team approach to amputation prevention: pioneers and milestones. J Vasc Surg 52 (2010), 3S–16S.
Van Gils, C.C., Wheeler, L.A., Mellstrom, M., Brinton, E.A., Mason, S., Wheeler, C.G., Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience. Diabetes Care 22 (1999), 678–683.
Wrobel, J.S., Robbins, J.M., Charns, M.P., Bonacker, K.M., Reiber, G.E., Pogach, L., Diabetes-related foot care at 10 Veterans Affairs medical centers: must do's associated with successful microsystems. Jt Comm J Qual Patient Saf 32 (2006), 206–213.
Driver, V.R., Madsen, J., Goodman, R.A., Reducing amputation rates in patients with diabetes at a military medical center. The Limb Preservation Service model. Diabetes Care 28 (2005), 248–253.
Armstrong, D.G., Bharara, M., White, M., Lepow, B., Bhatnagar, S., Fisher, T., et al. The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot. Diabetes Metab Res Rev 28 (2012), 514–518.
Sloan, F.A., Feinglos, M.N., Grossman, D.S., Receipt of care and reduction of lower extremity amputations in a nationally representative sample of U.S. elderly. Health Serv Res 45:Pt 1 (2010), 1740–1762.
Schmidt, B.M., Wrobel, J.S., Munson, M., Rothenberg, G., Holmes, C.M., Podiatry impact on high-low amputation ratio characteristics: a 16-year retrospective study. Diabetes Res Clin Pract 126 (2017), 272–277.
van Houtum, W.H., Rauwerda, J.A., Ruwaard, D., Schaper, N.C., Bakker, K., Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. Diabetes Care 27 (2004), 1042–1046.
Pedrosa, H., Boulton, A.J., Oliveira Dias, M.S., The diabetic foot in Brazil. Boulton, A.J., Cavanagh, P.R., Rayman, G., (eds.)The foot in diabetes, 2006, John Wiley & Sons, Hoboken, NJ, 364–374.
Anichini, R., Zecchini, F., Cerretini, I., Meucci, G., Fusilli, D., Alviggi, L., et al. Improvement of diabetic foot care after the implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study. Diabetes Res Clin Pract 75 (2007), 153–158.
Rubio, J.A., Aragón-Sánchez, J., Jiménez, S., Guadalix, G., Albarracín, A., Salido, C., et al. Reducing major lower extremity amputations after the introduction of a multidisciplinary team for the diabetic foot. Int Low Extrem Wounds 13 (2014), 22–26.
Canavan, R.J., Unwin, N.C., Kelly, W.F., Connolly, V.M., Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care. Continuous longitudinal monitoring using a standard method. Diabetes Care 31 (2008), 459–463.
Williams, D.T., Powell-Chandler, A., Qureshi, Q., Zaidi, A., Whitaker, C.J., Improved limb salvage for patients with vascular disease and tissue loss associated with new model of provision targeted at the diabetic foot. Diabetes Res Clin Pract 135 (2018), 50–57.
Eskelinen, E., Eskelinen, A., Albäck, A., Lepäntalo, M., Major amputation incidence decreases both in non-diabetic and in diabetic patients in Helsinki. Scand J Surg 95 (2006), 185–189.
Laakso, M., Honkasalo, M., Kiiski, J., Ala-Houhala, M., Haapasalo, H., Laine, H.J., et al. Re-organizing inpatient care saves legs in patients with diabetic foot infections. Diabetes Res Clin Pract 125 (2017), 39–46.
Hirsch, A.T., Duval, S., The global pandemic of peripheral artery disease. Lancet 382 (2013), 1312–1314.
Health in India. Government of India. Available at: http://mospi.nic.in/sites/default/files/publication_reports/nss_rep574.pdf Accessed December 7, 2018.
Kapoor, A., Vora, A., Nataraj, G., Mishra, S., Kerkar, P., Manjunath, C.N., Guidance on reuse of cardio-vascular catheters and devices in India: a consensus document. Indian Heart J 69 (2017), 357–363.
Katsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M., Karnabatidis, D., Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc, 2018, 7e011245, 10.1161/JAHA.118.011245 Accessed April 21, 2019.
de Graaff, J.C., Ubbink, D.T., Legemate, D.A., de Haan, R.J., Jacobs, M.J., Interobserver and intraobserver reproducibility of peripheral blood and oxygen pressure measurements in the assessment of lower extremity arterial disease. J Vasc Surg 33 (2001), 1033–1040.
Wang, Z., Hasan, R., Firwana, B., Elraiyah, T., Tsapas, A., Prokop, L., et al. A systematic review and meta-analysis of tests to predict wound healing in diabetic foot. J Vasc Surg 63 (2016), 29S–36S.e2.
Brownrigg, J., Hinchliffe, R., Apelqvist, J., Boyko, E., Fitridge, R., Mills, J., et al. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review. Diabetes Metab Res Rev 32:Suppl 1 (2016), 119–127.
Beropoulis, E., Stavroulakis, K., Schwindt, A., Stachmann, A., Torsello, G., Bisdas, T., Validation of the Wound, Ischemia, foot Infection (WIfI)classification system in nondiabetic patients treated by endovascular means for critical limb ischemia. J Vasc Surg 64 (2016), 95–103.
Ward, R., Dunn, J., Clavijo, L., Shavelle, D., Rowe, V., Woo, K., Outcomes of critical limb ischemia in an urban, safety net hospital population with high WIfI amputation scores. Ann Vasc Surg 38 (2017), 84–89.
Darling, J.D., McCallum, J.C., Soden, P.A., Meng, Y., Wyers, M.C., Hamdan, A.D., et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI)classification system following infrapopliteal endovascular interventions for critical limb ischemia. J Vasc Surg 64 (2016), 616–622.
Lijmer, J.G., Hunink, M.G., van den Dungen, J.J., Loonstra, J., Smit, A.J., ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 22 (1996), 391–398.
Aboyans, V., Ho, E., Denenberg, J.O., Ho, L.A., Natarajan, L., Criqui, M.H., The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 48 (2008), 1197–1203.
Salaun, P., Desormais, I., Lapebie, F.X., Riviere, A.B., Aboyans, V., Lacroix, P., et al. Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort. Angiology, 2018 3319718793566.
Larch, E., Minar, E., Ahmadi, R., Schnurer, G., Schneider, B., Stumpflen, A., et al. Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography. J Vasc Surg 25 (1997), 629–636.
Visser, K., Hunink, M.G., Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US—a meta-analysis. Radiology 216 (2000), 67–77.
Adriaensen, M.E., Kock, M.C., Stijnen, T., van Sambeek, M.R., van Urk, H., Pattynama, P.M., et al. Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations. Radiology 233 (2004), 385–391.
Collins, R., Burch, J., Cranny, G., Aguiar-Ibanez, R., Craig, D., Wright, K., et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ, 334, 2007, 1257.
Hingorani, A., Ascher, E., Markevich, N., Kallakuri, S., Schutzer, R., Yorkovich, W., et al. A comparison of magnetic resonance angiography, contrast arteriography, and duplex arteriography for patients undergoing lower extremity revascularization. Ann Vasc Surg 18 (2004), 294–301.
Hingorani, A.P., Ascher, E., Marks, N., Puggioni, A., Shiferson, A., Tran, V., et al. Limitations of and lessons learned from clinical experience of 1,020 duplex arteriography. Vascular 16 (2008), 147–153.
Met, R., Bipat, S., Legemate, D.A., Reekers, J.A., Koelemay, M.J., Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 301 (2009), 415–424.
Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities. Eur J Vasc Endovasc Surg 14 (1997), 91–95.
Faglia, E., Clerici, G., Scatena, A., Caminiti, M., Curci, V., Morabito, A., et al. Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study. Diabetes Res Clin Pract 103 (2014), 292–297.
Armstrong, E.J., Chen, D.C., Westin, G.G., Singh, S., McCoach, C.E., Bang, H., et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc, 3, 2014, e000697.
Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002), 71–86.
Antithrombotic Trialists' Collaboration Baigent, C., Blackwell, L., Collins, R., Emberson, J., Godwin, J., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373 (2009), 1849–1860.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996), 1329–1339.
Hiatt, W.R., Fowkes, F.G., Heizer, G., Berger, J.S., Baumgartner, I., Held, P., et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med 376 (2017), 32–40.
Anand, S.S., Bosch, J., Eikelboom, J.W., Connolly, S.J., Diaz, R., Widimsky, P., et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 391 (2018), 219–229.
Anand, S., Yusuf, S., Xie, C., Pogue, J., Eikelboom, J., Budaj, A., et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357 (2007), 217–227.
Mills, E.J., O'Regan, C., Eyawo, O., Wu, P., Mills, F., Berwanger, O., et al. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients. Eur Heart J 32 (2011), 1409–1415.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002), 7–22.
Meade, T., Zuhrie, R., Cook, C., Cooper, J., Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ, 325, 2002, 1139.
Leng, G.C., Price, J.F., Jepson, R.G., Lipid-lowering for lower limb atherosclerosis. Cochrane Database Syst Rev, 2, 2000, CD000123.
Aung, P.P., Maxwell, H.G., Jepson, R.G., Price, J.F., Leng, G.C., Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev, 4, 2007, CD000123.
Rodriguez, F., Maron, D.J., Knowles, J.W., Virani, S.S., Lin, S., Heidenreich, P.A., Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease. JAMA Cardiol 2 (2017), 47–54.
Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
Bavry, A.A., Anderson, R.D., Gong, Y., Denardo, S.J., Cooper-Dehoff, R.M., Handberg, E.M., et al. Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy. Hypertension 55 (2010), 48–53.
ACCORD Study Group Cushman, W.C., Evans, G.W., Byington, R.P., Goff, D.C. Jr., Grimm, R.H. Jr., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362 (2010), 1575–1585.
Moise, N., Huang, C., Rodgers, A., Kohli-Lynch, C.N., Tzong, K.Y., Coxson, P.G., et al. Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: the Cardiovascular Disease Policy Model. Hypertension 68 (2016), 88–96.
Nathan, D.M., Cleary, P.A., Backlund, J.Y., Genuth, S.M., Lachin, J.M., Orchard, T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005), 2643–2653.
van Dieren, S., Kengne, A.P., Chalmers, J., Beulens, J.W., Davis, T.M., Fulcher, G., et al. Intensification of medication and glycaemic control among patients with type 2 diabetes—the ADVANCE trial. Diabetes Obes Metab 16 (2014), 426–432.
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F.L., Powe, N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 (2004), 421–431.
Palmer, S.C., Mavridis, D., Nicolucci, A., Johnson, D.W., Tonelli, M., Craig, J.C., et al. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis. JAMA 316 (2016), 313–324.
Nawaz, S., Cleveland, T., Gaines, P.A., Chan, P., Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol 53 (1998), 342–344.
Goergen, S.K., Rumbold, G., Compton, G., Harris, C., Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology 254 (2010), 261–269.
Blomster, J.I., Woodward, M., Zoungas, S., Hillis, G.S., Harrap, S., Neal, B., et al. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation)trial. BMJ Open, 6, 2016, e009668.
Newhall, K., Suckow, B., Spangler, E., Brooke, B.S., Schanzer, A., Tan, T.W., et al. Impact and duration of brief surgeon-delivered smoking cessation advice on attitudes regarding nicotine dependence and tobacco harms for patients with peripheral arterial disease. Ann Vasc Surg 38 (2017), 113–121.
Athyros, V.G., Tziomalos, K., Katsiki, N., Gossios, T.D., Giouleme, O., Anagnostis, P., et al. The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study. Curr Vasc Pharmacol 11 (2013), 779–784.
Dagenais, G.R., Yi, Q., Lonn, E., Sleight, P., Ostergren, J., Yusuf, S., Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE)trial. Eur J Cardiovasc Prev Rehabil 12 (2005), 75–81.
Kondo, T., Osugi, S., Shimokata, K., Honjo, H., Morita, Y., Maeda, K., et al. Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers. Circ J 75 (2011), 2885–2892.
Schanzer, A., Mega, J., Meadows, J., Samson, R.H., Bandyk, D.F., Conte, M.S., Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 48 (2008), 1464–1471.
Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)trial: A survival prediction model to facilitate clinical decision making. J Vasc Surg 51:Suppl (2010), 52S–68S.
Meltzer, A.J., Graham, A., Connolly, P.H., Meltzer, E.C., Karwowski, J.K., Bush, H.L., et al. The Comprehensive Risk Assessment for Bypass (CRAB)facilitates efficient perioperative risk assessment for patients with critical limb ischemia. J Vasc Surg 57 (2013), 1186–1195.
Simons, J.P., Goodney, P.P., Flahive, J., Hoel, A.W., Hallett, J.W., Kraiss, L.W., et al. A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass. J Vasc Surg 63 (2016), 990–997.
Biancari, F., Salenius, J.P., Heikkinen, M., Luther, M., Ylonen, K., Lepantalo, M., Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg 31 (2007), 217–225 discussion: 226-7.
Lavery, L.A., Barnes, S.A., Keith, M.S., Seaman, J.W. Jr., Armstrong, D.G., Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. Diabetes Care 31 (2008), 26–29.
Sheehan, P., Jones, P., Caselli, A., Giurini, J.M., Veves, A., Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26 (2003), 1879–1882.
Snyder, R.J., Cardinal, M., Dauphinee, D.M., Stavosky, J., A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks. Ostomy Wound Manage 56 (2010), 44–50.
Cardinal, M., Eisenbud, D.E., Phillips, T., Harding, K., Early healing rates and wound area measurements are reliable predictors of later complete wound closure. Wound Repair Regen 16 (2008), 19–22.
Abu Dabrh, A.M., Steffen, M.W., Undavalli, C., Asi, N., Wang, Z., Elamin, M.B., et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 62 (2015), 1642–1651.e3.
Cull, D.L., Manos, G., Hartley, M.C., Taylor, S.M., Langan, E.M., Eidt, J.F., et al. An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system. J Vasc Surg 60 (2014), 1535–1541.
Zhan, L.X., Branco, B.C., Armstrong, D.G., Mills, J.L. Sr., The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI)correlates with risk of major amputation and time to wound healing. J Vasc Surg 61 (2015), 939–944.
Darling, J.D., McCallum, J.C., Soden, P.A., Buck, D.B., Zettervall, S.L., Ultee, K.H., et al. VESS16. Predictive ability of the SVS Lower Extremity Guidelines Committee Wound, Ischemia, and Foot Infection (WIfI)scale for first-time revascularizations. J Vasc Surg 61 (2015), 24S–25S.
Causey, M.W., Ahmed, A., Wu, B., Gasper, W.J., Reyzelman, A., Vartanian, S.M., et al. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg 63 (2016), 1563–1573.e2.
Robinson, W.P., Loretz, L., Hanesian, C., Flahive, J., Bostrom, J., Lunig, N., et al. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI)score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center. J Vasc Surg 66 (2017), 488–498.e2.
Seeger, J.M., Schmidt, J.H., Flynn, T.C., Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery. Ann Surg 205 (1987), 733–739.
Wengerter, K.R., Veith, F.J., Gupta, S.K., Ascer, E., Rivers, S.P., Influence of vein size (diameter)on infrapopliteal reversed vein graft patency. J Vasc Surg 11 (1990), 525–531.
Schanzer, A., Hevelone, N., Owens, C.D., Belkin, M., Bandyk, D.F., Clowes, A.W., et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 46 (2007), 1180–1190 discussion: 1190.
Harward, T.R., Ingegno, M.D., Carlton, L., Flynn, T.C., Seeger, J.M., Limb-threatening ischemia due to multilevel arterial occlusive disease. Simultaneous or staged inflow/outflow revascularization. Ann Surg 221 (1995), 498–503 discussion: 503-6.
Zukauskas, G., Ulevicius, H., Triponis, V., Sequential aortofemoropopliteal/distal bypass for treatment of critical lower-limb ischaemia. Cardiovasc Surg 3 (1995), 671–678.
Jongkind, V., Akkersdijk, G.J., Yeung, K.K., Wisselink, W., A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 52 (2010), 1376–1383.
Ye, W., Liu, C.W., Ricco, J.B., Mani, K., Zeng, R., Jiang, J., Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 53 (2011), 1728–1737.
Deloose, K., Bosiers, M., Callaert, J., Verbist, J., Vermassen, F., Scheinert, D., et al. Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results. J Cardiovasc Surg (Torino)58 (2017), 416–421.
Indes, J.E., Pfaff, M.J., Farrokhyar, F., Brown, H., Hashim, P., Cheung, K., et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther 20 (2013), 443–455.
Chiu, K.W., Davies, R.S., Nightingale, P.G., Bradbury, A.W., Adam, D.J., Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg 39 (2010), 460–471.
Ricco, J.B., Probst, H., Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg 47 (2008), 45–53 discussion: 53-4.
Kang, J.L., Patel, V.I., Conrad, M.F., Lamuraglia, G.M., Chung, T.K., Cambria, R.P., Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg 48 (2008), 872–877.
Ballotta, E., Gruppo, M., Mazzalai, F., Da Giau, G., Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery 147 (2010), 268–274.
Chang, R.W., Goodney, P.P., Baek, J.H., Nolan, B.W., Rzucidlo, E.M., Powell, R.J., Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 48 (2008), 362–367.
Baumann, F., Ruch, M., Willenberg, T., Dick, F., Do, D.D., Keo, H.H., et al. Endovascular treatment of common femoral artery obstructions. J Vasc Surg 53 (2011), 1000–1006.
Bonvini, R.F., Rastan, A., Sixt, S., Noory, E., Schwarz, T., Frank, U., et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol 58 (2011), 792–798.
Gouëffic, Y., Della Schiava, N., Thaveau, F., Rosset, E., Favre, J.P., Salomon du Mont, L., et al. Stenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv 10 (2017), 1344–1354.
Siracuse, J.J., Menard, M.T., Eslami, M.H., Kalish, J.A., Robinson, W.P., Eberhardt, R.T., et al. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative. J Vasc Surg 63 (2016), 958–965.e1.
Almasri, J., Adusumalli, J., Asi, N., Lakis, S., Alsawas, M., Prokop, L., et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg 68 (2018), 624–633.
Chae, K.J., Shin, J.Y., Is angiosome-targeted angioplasty effective for limb salvage and wound healing in diabetic foot? A meta-Analysis. PLoS One, 11, 2016, e0159523.
Jongsma, H., Bekken, J.A., Akkersdijk, G.P., Hoeks, S.E., Verhagen, H.J., Fioole, B., Angiosome-directed revascularization in patients with critical limb ischemia. J Vasc Surg 65 (2017), 1208–12019.e1.
Biancari, F., Juvonen, T., Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J Vasc Endovasc Surg 47 (2014), 517–522.
Sumpio, B.E., Forsythe, R.O., Ziegler, K.R., van Baal, J.G., Lepantalo, M.J., Hinchliffe, R.J., Clinical implications of the angiosome model in peripheral vascular disease. J Vasc Surg 58 (2013), 814–826.
Azuma, N., Uchida, H., Kokubo, T., Koya, A., Akasaka, N., Sasajima, T., Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?. Eur J Vasc Endovasc Surg 43 (2012), 322–328.
Schillinger, M., Sabeti, S., Loewe, C., Dick, P., Amighi, J., Mlekusch, W., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006), 1879–1888.
Saxon, R.R., Dake, M.D., Volgelzang, R.L., Katzen, B.T., Becker, G.J., Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19 (2008), 823–832.
Dake, M.D., Ansel, G.M., Jaff, M.R., Ohki, T., Saxon, R.R., Smouse, H.B., et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4 (2011), 495–504.
Rosenfield, K., Jaff, M.R., White, C.J., Rocha-Singh, K., Mena-Hurtado, C., Metzger, D.C., et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373 (2015), 145–153.
Mills, J.L., Fujitani, R.M., Taylor, S.M., Contribution of routine intraoperative completion arteriography to early infrainguinal bypass patency. Am J Surg 164 (1992), 506–510 discussion: 510-1.
Bandyk, D.F., Mills, J.L., Gahtan, V., Esses, G.E., Intraoperative duplex scanning of arterial reconstructions: fate of repaired and unrepaired defects. J Vasc Surg 20 (1994), 426–432 discussion: 432-3.
Ubbink, D.T., Vermeulen, H., Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev, 2, 2013, CD004001.
Karanth, V.K., Karanth, T.K., Karanth, L., Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease. Cochrane Database Syst Rev, 12, 2016, CD011519.
Abu Dabrh, A.M., Steffen, M.W., Asi, N., Undavalli, C., Wang, Z., Elamin, M.B., et al. Nonrevascularization-based treatments in patients with severe or critical limb ischemia. J Vasc Surg 62 (2015), 1330–1339.e13.
Vietto, V., Franco, J.V., Saenz, V., Cytryn, D., Chas, J., Ciapponi, A., Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev, 1, 2018, CD006544.
Smith, F.B., Bradbury, A., Fowkes, G., Intravenous naftidrofuryl for critical limb ischaemia. Cochrane Database Syst Rev, 7, 2012, CD002070.
Kranke, P., Bennett, M.H., Martyn-St James, M., Schnabel, A., Debus, S.E., Weibel, S., Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev, 6, 2015, CD004123.
Game, F.L., Apelqvist, J., Attinger, C., Hartemann, A., Hinchliffe, R.J., Löndahl, M., et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev 32:Suppl 1 (2016), 154–168.
Santema, K.T., Stoekenbroek, R.M., Koelemay, M.J., Reekers, J.A., van Dortmont, L.M., Oomen, A., et al. Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care 41 (2018), 112–119.
Peeters Weem, S.M., Teraa, M., de Borst, G.J., Verhaar, M.C., Moll, F.L., Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials. Eur J Vasc Endovasc Surg 50 (2015), 775–783.
Elsherif, M., Tawfick, W., Canning, P., Hynes, N., Sultan, S., Quality of time spent without symptoms of disease or toxicity of treatment for transmetatarsal amputation versus digital amputation in diabetic patients with digital gangrene. Vascular 26 (2018), 142–150.
Siracuse, J.J., Jones, D.W., Meltzer, E.C., Graham, A.R., Salzler, G.G., Connolly, P.H., et al. Impact of “do not resuscitate” status on the outcome of major vascular surgical procedures. Ann Vasc Surg 29 (2015), 1339–1345.
Aziz, H., Branco, B.C., Braun, J., Hughes, J.D., Goshima, K.R., Trinidad-Hernandez, M., et al. The influence of do-not-resuscitate status on the outcomes of patients undergoing emergency vascular operations. J Vasc Surg 61 (2015), 1538–1542.
Reed, A.B., Delvecchio, C., Giglia, J.S., Major lower extremity amputation after multiple revascularizations: was it worth it?. Ann Vasc Surg 22 (2008), 335–340.
Rollins, D.L., Towne, J.B., Bernhard, V.M., Baum, P.L., Isolated profundaplasty for limb salvage. J Vasc Surg 2 (1985), 585–590.
Miksic, K., Novak, B., Profunda femoris revascularization in limb salvage. J Cardiovasc Surg (Torino)27 (1986), 544–552.
Ayoub, M.M., Solis, M.M., Rogers, J.J., Dalton, M.L., Thru-knee amputation: the operation of choice for non-ambulatory patients. Am Surg 59 (1993), 619–623.
Taylor, S.M., Kalbaugh, C.A., Cass, A.L., Buzzell, N.M., Daly, C.A., Cull, D.L., et al. “Successful outcome” after below-knee amputation: an objective definition and influence of clinical variables. Am Surg 74 (2008), 607–612 discussion: 612-3.
Webster, J.B., Hakimi, K.N., Czerniecki, J.M., Prosthetic fitting, use, and satisfaction following lower-limb amputation: a prospective study. J Rehabil Res Dev, 49, 2012, 1493.
Glaser, J.D., Bensley, R.P., Hurks, R., Dahlberg, S., Hamdan, A.D., Wyers, M.C., et al. Fate of the contralateral limb after lower extremity amputation. J Vasc Surg 58 (2013), 1571–1577.e1.
Bradley, L., Kirker, S., Secondary prevention of arteriosclerosis in lower limb vascular amputees: a missed opportunity. Eur J Vasc Endovasc Surg 32 (2006), 491–493.
Bedenis, R., Lethaby, A., Maxwell, H., Acosta, S., Prins, M.H., Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev, 2, 2015, CD000535.
Abbruzzese, T.A., Havens, J., Belkin, M., Donaldson, M.C., Whittemore, A.D., Liao, J.K., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004), 1178–1185.
Henke, P.K., Blackburn, S., Proctor, M.C., Stevens, J., Mukherjee, D., Rajagopalin, S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004), 357–365.
Suckow, B.D., Kraiss, L.W., Schanzer, A., Stone, D.H., Kalish, J., DeMartino, R.R., et al. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. J Vasc Surg 61 (2015), 126–133.
Brown, J., Lethaby, A., Maxwell, H., Wawrzyniak, A.J., Prins, M.H., Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev, 4, 2008, CD000535.
Willigendael, E.M., Teijink, J.A., Bartelink, M.L., Peters, R.J., Buller, H.R., Prins, M.H., Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg 42 (2005), 67–74.
Hobbs, S.D., Bradbury, A.W., Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach. Eur J Vasc Endovasc Surg 26 (2003), 341–347.
Belch, J.J., Dormandy, J., Biasi, G.M., Cairols, M., Diehm, C., Eikelboom, B., et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR)trial. J Vasc Surg 52 (2010), 825–833 833.e1-2.
Gassman, A.A., Degner, B.C., Al-Nouri, O., Philippi, L., Hershberger, R., Halandras, P., et al. Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency. Vascular 22 (2014), 105–111.
Bhatt, D.L., Fox, K.A., Hacke, W., Berger, P.B., Black, H.R., Boden, W.E., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006), 1706–1717.
Cassar, K., Ford, I., Greaves, M., Bachoo, P., Brittenden, J., Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty. Br J Surg 92 (2005), 159–165.
Strobl, F.F., Brechtel, K., Schmehl, J., Zeller, T., Reiser, M.F., Claussen, C.D., et al. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease. J Endovasc Ther 20 (2013), 699–706.
Tepe, G., Bantleon, R., Brechtel, K., Schmehl, J., Zeller, T., Claussen, C.D., et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol 22 (2012), 1998–2006.
Mills, J.L. Sr., Wixon, C.L., James, D.C., Devine, J., Westerband, A., Hughes, J.D., The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair. J Vasc Surg 33 (2001), 273–278 discussion: 278-80.
Landry, G.J., Moneta, G.L., Taylor, L.M., Edwards, J.M., Yeager, R.A., Porter, J.M., Long-term outcome of revised lower-extremity bypass grafts. J Vasc Surg 35 (2002), 56–63.
Nguyen, L.L., Conte, M.S., Menard, M.T., Gravereaux, E.C., Chew, D.K., Donaldson, M.C., et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg 40 (2004), 916–923.
Bui, T.D., Mills, J.L., Ihnat, D.M., Gruessner, A.C., Goshima, K.R., Hughes, J.D., The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance. J Vasc Surg 55 (2012), 346–352.
Humphries, M.D., Pevec, W.C., Laird, J.R., Yeo, K.K., Hedayati, N., Dawson, D.L., Early duplex scanning after infrainguinal endovascular therapy. J Vasc Surg 53 (2011), 353–358.
Elraiyah, T., Tsapas, A., Prutsky, G., Domecq, J.P., Hasan, R., Firwana, B., et al. A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers. J Vasc Surg 63 (2016), 46S–58S.e2.